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Isolamento e caracterização de microrganismos vaginais e a sua 
associação com  a Vaginose Bacteriana 
 
RESUMO 
 
A vaginose bacteriana (VB) é uma das condições ginecológicas mais comuns 
que afetam as mulheres em idade fértil em todo o mundo, tendo sido associada a graves 
consequências para a saúde pública. Devido à sua complexidade e à diversidade dos 
microorganismos presentes, a sua etiologia é desconhecida. Dados recentes associaram 
a presença de biofilmes anaeróbios, tanto na vagina saudável como em VB, levando à 
teoria de que os microorganismos que formam biofilme, como Gardnerella vaginalis, 
podem ser relevantes para a etiologia da VB. Biofilmes são estruturas complexas que 
protegem os microorganismos podendo conferir resistência aos antibióticos e às defesas 
naturais do hospedeiro. Assim, o objetivo deste trabalho foi isolar e caracterizar a 
população microbiana presente na vagina de mulheres portuguesas. Para isso, foram 
recolhidas 54 amostras de exsudado vaginal de mulheres saudáveis ou diagnosticadas 
com BV. Após a caracterização inicial, 15 estirpes foram isoladas e identificadas. O 
passo seguinte consistiu na caracterização fenotípica das estirpes, como a capacidade 
intrínseca para formar biofilme e a tolerância a antibióticos, através da determinação das 
concentrações mínimas inibitórias (CMI´s). A capacidade intrínseca de formação de 
biofilme de cada um dos isolados foi avaliada em condições anaeróbias durante 48 
horas utilizando diferentes meios de crescimento. Foi possível observar que todas as 
estirpes isoladas apresentaram elevada capacidade para formar biofilme, dependendo 
dos meios de crescimento utilizados. As estirpes que demonstraram maior capacidade 
para formar biofilme foram G. vaginalis, Enterococcus faecalis, Streptococcus spp., 
Bifidobacterium breve e Propionibacterium acnes. Além disso, os resultados da 
susceptibilidade antimicrobiana demonstraram que a maior parte dos microrganismos 
apresentaram CMI´s semelhantes às previamente descritas na literatura. 
Este trabalho permitiu fazer uma caracterização da flora microbiana vaginal de 
mulheres portuguesas e é o primeiro estudo deste tipo em Portugal. Estes resultados 
devem ser tidos em conta na investigação da epidemiologia e patogénese da VB. 
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Isolation and characterization of vaginal microorganisms and its 
association with Bacterial Vaginosis 
 
ABSTRACT 
 
Bacterial vaginosis (BV) is one of the most common gynaecological conditions 
affecting women in reproductive age worldwide, being linked to serious public health 
consequences. Due to their complexity and to the diversity of microorganisms involved 
in this condition, the exact aetiology is inconclusive, but recent reports referring to the 
presence of anaerobic biofilms led to the theory that the microorganisms which form the 
biofilm, like Gardnerella vaginalis, may be relevant for the aetiology of BV. Biofilms 
are complex structures that protect the microorganisms involved increasing their 
resistance to antibiotics and natural defences of the body. As such, the aim of this work 
was to isolate and characterise the microbial population present in the vagina of 
Portuguese women. In order to achieve this, 54 samples of vaginal exudate were 
collected in clinical settings from Portuguese women that were either healthy or had 
been diagnosed with BV. After an initial characterization, 15 unique strains were 
isolated and identified. The next step was the phenotypic characterization of the isolated 
strains, which included the determination of their intrinsic capacity to form biofilm and 
tolerance to some antibiotics typically prescribed by physicians around the world, by 
determining the minimum inhibitory concentrations (MIC). The intrinsic capacity to 
grow as biofilm of each one of the isolate was assessed under anaerobic conditions for 
48 hours and using different media. It was observed that all isolates had the capacity to 
form biofilm, but this was depending on the growth media used. The strains that showed 
a higher capacity for biofilm formation were G. vaginalis, Enterococcus faecalis, 
Streptococcus spp., Bifidobacterium breve and Propionibacterium acnes. Furthermore, 
results of antimicrobial susceptibility assays showed that for the most part of 
microorganisms had an MIC similar to those previously reported in the literature.  
This work allowed the characterization of the vaginal microbial flora in 
Portuguese woman and is the first study of this kind in Portugal. These results should be 
taken into account when researching the epidemiology and pathogenesis of BV. 
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1.1. Vaginal flora microenvironment 
Microbial communities have a strong inﬂuence in human health and quality of 
life. Therefore, the bacterial community of the human vagina can have a profound impact 
on women's health, since microorganisms play a critical role in determining the 
biochemical profile and inflammation of the vaginal environment (Srinivasan and 
Fredericks, 2008). 
Despite decades of investigations, based on growth technologies of human vaginal 
flora, recent studies using culture independent methods significantly increased the 
knowledge of bacterial diversity in this important niche (Donachie et al., 2007). Diverse 
microorganisms can be found in healthy women that are mostly colonized with 
lactobacilli such as Lactobacillus crispatus, Lactobacillus jensenii and Lactobacillus 
gasseri (Zhou et al., 2004) though a variety of other bacteria may be present (Vásquez et 
al., 2002) (Figure 1.1). 
  
 
Figure 1.1. Gram staining of vaginal fluid smear from clinical sample of healthy woman that we prepared 
(original magnification, x1000). There is a predominance of Lactobacillus spp. which are responsible for 
suppressing the growth of other species. 
The definition of a healthy vaginal environment is more complex than originally 
thought due to bacterial diversity observed among individuals (Kim et al., 2009). Thus, 
the identity and diversity of these populations remain largely unknown and the complex 
interaction between the various members of the vaginal flora is still poorly understood 
(Zhou et al., 2004). This means that it is essential to have accurate knowledge about the 
microbial ecosystem of the human vagina of healthy women, because there is still much 
to understand about how bacterial communities in this niche promote health and facilitate 
disease (Srinivasan and Fredericks, 2008). 
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1.2. Bacterial Vaginosis 
 Bacterial vaginosis (BV) is the main vaginal disorder of women in reproductive 
age worldwide (Harwich et al., 2010) and, although not life threatening, leads to 
increased risk of preterm delivery (Hillier et al., 1995), and more severe gynecological 
infections such as pelvic inflammatory disease (Haggerty et al., 2004) and increase risk of 
Human Immunodeficiency Virus (HIV) infection acquisition (Schmid et al., 2000).  
 The etiology of this condition has been long debated, and despite the impact on 
women's health, little is known about its cause and pathogenesis. This microecologic 
disorder is characterized by not being associated with a specific etiologic agent 
(Aroutcheva et al., 2001).  
 Women without BV typically show Gram-positive rods, revealing a predominance 
of lactobacilli, particularly L. crispatus and L.  jensenii (Livengood, 2009). However, it is 
likely that over time, microbial communities in the human vagina may be affected in a 
negative way due to various factors, such as woman's age, hormonal fluctuations (menses, 
or contraception), pregnancy, sexual activity (frequency of sex and numbers of sexual 
partners), health status (such as diabetes, infections) and as well as various lifestyle habits 
and hygiene practices (such as douching) (Srinivasan and Fredericks, 2008).  
 During BV, most of the beneficial bacteria (like L. crispatus, L. jensenii, L. 
gasseri) (Srinivasan and Fredericks, 2008) (Figure 1.1) are replaced, by concomitant 
overgrowth of anaerobic or facultative bacteria (Fredricks et al., 2005) generally Gram-
negative or Gram-variables cocci and rods, normally associated with the gastrointestinal 
tract. Cultures of vaginal fluids from individuals with BV microorganisms typically 
present bacteria such as Gardnerella vaginalis and a combination of other bacteria such 
as, Prevotella, Porphyromonas, Mobiluncus spp., Atopobium vaginae and Mycoplasma 
spp. (Livengood, 2009). 
 Lactobacilli are responsible for promoting a healthy ecosystem, producing lactic 
acid, hydrogen peroxide (H2O2) and bacteriocins, which have antimicrobial properties 
that inhibit microorganisms that are pathogens of this niche, maintaining a healthy 
ecosystem (Srinivasan and Fredericks, 2008). The growth of anaerobic bacteria is 
associated with increased production of proteolytic enzymes, which break the vaginal 
epithelial peptides into a variety of amines that at, an elevated pH, becomes volatile 
causing bad odor. Amines are associated with an increase in transudation and exfoliation 
University of Minho 
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of squamous epithelial cells, resulting in a white fluid that is expelled from the vagina, 
creating an imbalance in the vaginal flora (Sobel, 2000). 
 It is unknown if the primary event of BV is the loss of lactobacilli or the 
acquisition of facultative anaerobic bacterial communities found in this infection, or if 
these two events are simultaneous processes (Figure 1.2). It is also possible that the 
primary etiologic agent is another unknown factor, that changes in vaginal flora reflect a 
downstream event in the pathogenesis of BV (Srinivasan and Fredericks, 2008). 
 
 
 
 
 
 
 
Figure 1.2. Two models explaining the pathogenesis of BV, the loss of lactobacilli model suggests that 
there is a decrease in the production of H2O2 by lactobacilli as the main event, which allows the 
proliferation of anaerobic bacteria, resulting in BV; while the primary pathogenic model suggests that entry 
of facultative anaerobic bacteria will cause loss of lactobacilli resulted in BV. Adapted from Srinivasan and 
Fredericks, (2008). 
1.2.1. Clinical features and diagnosis of BV 
The diagnosis of BV is generally done through a series of clinical criteria from 
pelvic examination and microscopic examination of the exudate (Amsel's criteria), or by 
microscopic interpretation of vaginal fluid by Gram staining technique (Nugent criteria) 
(Srinivasan and Fredericks, 2008). The Amsel criteria are the most frequently method 
used to diagnose BV in most countries, including Portugal (Henriques et al., 2012). At 
least 3 of 4 Amsel criteria must be present to establish the diagnosis of BV, including the 
increase of pH of vaginal fluid > 4.5; positive "wiff test" in the detection of an odor 
similar to rotten fish (with the addition of 10% potassium hydroxide (KOH ) in a sample 
containing vaginal fluid); presence of ―clue cells‖ (> 20%) in vaginal fluid where the 
Decrease in H2O2-producing 
lactobacilli 
Overgrowth of facultative & 
anaerobic bacterial 
opportunists 
Lactobacillus depletion model Primary pathogen model 
Entry of facultative & 
anaerobic bacterial 
Displacement of lactobacilli 
Bacterial vaginosis 
Insult 
? 
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vaginal epithelial cells are coated with bacteria creating indistinct borders (Figure 1.3) 
and white vaginal discharge, with homogeneous characteristics (Srinivasan and 
Fredericks, 2008). 
 
 
 
 
Figure 1.3. "Clue cells" in both images (original magnification, x400). a) some cells have irregular edges 
that define the "clue cells", those that do not have this characteristic are not "clue cells"; b) represents the 
normal vaginal bacterial microscopy image bacterioscopy, in which a cell 1 is a "clue cell" in which the G. 
vaginalis bacterium is adhered to the surface of cell, while in the cell 2 does not. Adapted from Livengood, 
(2009). 
For the clinical diagnosis of BV, Nugent’s criteria form a standardized method of 
Gram stain interpretation of vaginal samples to detect the shift of normal vaginal flora to 
other microorganism allowing the scoring system of vaginal smears (Delaney and 
Andrew, 2001). The Nugent score is calculated by assessing the presence of some 
microorganisms in vaginal smears that are graded on a scale based on the presence or 
absence of some microorganisms, such as large Gram-positive rods - Lactobacillus 
morphotypes (decrease in Lactobacillus - scored as 0 to 4), small Gram-variable rods - G. 
vaginalis morphotypes (scored as 0 to 4), curved Gram-variable rods - Mobiluncus spp. 
morphotypes (scored as 0 to 2). Therefore, the score can range from 0 to 10 and score 
between 7 to 10 are classified as BV (Sha et al., 2005) (Table 1.1).  
For these two evaluation criteria of vaginal flora samples, Nugent scoring allows 
the evaluation of a change in vaginal flora continuously. Because Amsel criteria are 
dependent on the accuracy of the clinician, the Nugent score was favored for diagnosing 
BV due to its higher sensitivity and reproducibility (Onderdonk et al., 1977). 
Nevertheless, assessment of from vaginal smear slides samples can also be subjective and 
thus requires the experience of a reader (Chaijareenont et al., 2004). 
 
 
b) a) 
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Table 1.1. Scheme for grading Gram stained vaginal contents. Adapted from Livengood, (2009). 
Score 
Lactobacillus 
Morphotypes 
Gardnerella and Bacteroides spp. 
Morphotypes 
Curved Gram-Variable 
Rods 
0 4 + 0 0 
1 3 + 1 + 1 + or 2 + 
2 2 + 2 + 3 + or 4 + 
3 1 + 3 + 
 4 0 4 +   
   
 
Total Interpretation 
 
0 – 3  Normal 
 
4 – 6 Intermediate 
 
7 - 10 Bacterial vaginosis 
 
Morphotypes are scored as the average number seen per oil immersion field. Note that less weight is given 
to curved Gram-variable rods. Total score = lactobacilli + G. vaginalis and bacteroides spp. + curved rods. 
Quantitation: 0, No morphotypes present; 1 +, < 1 morphotype present; 2 +, 1 to 4 morphotypes present; 3 
+, 5 to 30 morphotypes present; 4 +, 30 or more morphotypes present. 
1.2.2. Treatment of BV 
 Current research has revealed more detailed aspects for the treatment of BV. Aims 
of the treatments of BV have two main goals: to eradicate the anaerobic microorganisms, 
and to allow growth of lactobacilli producing H2O2.  
 Many studies have been performed in order to find antibiotics that can specifically 
eradicate the anaerobic microorganisms that cause the symptoms of BV, trying to 
overcome the resistance that these organisms sometimes show to multiple antibiotics. 
Results of several experiments demonstrate that the fact that in BV the vaginal flora is 
comprised of several Gram-variable bacteria, like G. vaginalis, antimicrobials specifically 
active against Gram-positive or Gram-negative bacteria, have little or no action against 
Gram-variables microorganisms, explaining the common resistance to them (Gilbert et 
al., 1997). 
 In an attempt to find antimicrobial agents active against microorganisms normally 
associated with BV, including the bacteria G. vaginalis (Kharsany et al., 1993), various 
concentrations of antimicrobials were tested to find the minimum concentration capable 
of inhibiting the growth of pathogenic microorganisms, called a Minimum Inhibitory 
Concentration (MIC), as shown on table 1.2 (Kharsany et al., 1993). 
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Table 1.2. In vitro susceptibility of 93 strains of G. vaginalis to 25 antimicrobial agents. Adapted from 
Kharsany et al., (1993). 
Test agent MIC (µg/ml) 
  Range 50% 90% 
Metronidazole 2.0 - 128.0 8.0 16.0 
2-Hydroxy
a
 0.25-16.0 1.0 4.0 
Tinidazole 1.0-128.0 8.0 8.0 
Penicillin G 0.015-0.5 0.12 0.5 
Ampicillin 0.03-1.0 0.5 0.5 
Cefamandole 0.12-2.0 1.0 2.0 
Cefoxitin 0.06-4.0 1.0 1.0 
Cefuroxime 0.06-4.0 1.0 4.0 
Cefotaxime 0.25-4.0 2.0 2.0 
Ceftriaxone 0.06-4.0 0.5 2.0 
Aztreonam 4.0-32.0 32.0 32.0 
Imipenem 0.06-1.0 0.25 1.0 
Tetracycline 2.0-128.0 64.0 64.0 
Minocycline 0.12-16.0 2.0 16.0 
Erythromycin 0.007-0.06 0.03 0.06 
Clindamycin 0.007-0.03 0.01 0.03 
Vancomycin 0.12-0.5 0.25 0.5 
LY146032 0.5-8.0 4.0 8.0 
Chloramphenicol 0.5-2.0 1.0 2.0 
Amikacin 8.0-128.0 32.0 128.0 
Rifampin 0.5-0.5 1.0 2.0 
Ciprofloxacin 1.0-4.0 1.0 2.0 
Sulfamethoxazole 128.0-128.0 >128.0 >128.0 
Trimethoptim 0.5-4.0 2.0 4.0 
Co-trimoxazole
b
 4.0-64.0 64.0 64.0 
 
a 2-Hydroxymetabolite of metronidazole [1-(2-hydroxyethyl)-2 hydroxymethyl- 1,5-
nitroimidazole] 
 
b sulfamethoxazole-trimethoprim in a 19:1 ratio.     
     
  
 Recent investigations indicate that following intravaginal treatment with 
antibiotics such as metronidazole or clindamycin (Santiago et al., 2012) the cure rates 
were between 80 - 90% at the end of treatment (Livengood, 2009). However, a study 
suggests that three months after the end of therapy, there was a possible recurrence of BV 
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(Polatti, 2012). A study in Portugal on the perception of specialist doctors regarding to 
BV, also reported that the recurrence of these microorganisms after antimicrobial 
chemotherapy is high (Henriques et al., 2012). This relapse can occur due to inadequate 
treatment of microorganisms associated with BV, due to the resistance to metronidazole 
and others antibiotics or due to the fact that these microorganisms have recently been 
recognized as biofilm-forming (described in section 1.4.3). Because of these 
complications, with relapse of BV, new solutions have been proposed and Nyijesy and his 
collaborators demonstrated that the regeneration of lactobacilli using preparations of 
probiotic lactobacilli, which are known to be specialized organisms which dominate the 
healthy vagina, is likely to happen (Nyirjesy et al., 2006). However, this research has 
been hampered by the complications involving both the application of probiotic 
Lactobacillus spp., such as dominance by these organisms, such as L. crispatus, L. 
rhamnosus, and L. reuteri (Livengood, 2009) over other existing microorganisms.  
1.3. The microbiology of BV and role of recently defined BV-associated 
bacteria 
1.3.1. The etiology of BV 
 BV is considered a polymicrobial condition, and recently several new fastidious 
bacteria have been found to be associated with BV.  
 An attempt to find a single etiological agent to explain the pathogenesis of BV has 
been inconclusive (Ferris et al., 2007). Particular attention has been attributed to G. 
vaginalis, as this bacterium can be found in the vaginal flora of a majority of women with 
BV (95% of cases); however is also present in 50% of healthy vaginal flora (Livengood, 
2009). The bacteria Mobiluncus spp., curved bacilli highly mobile, is found only when 
BV is detected, but only 50% of cases of BV (Nyirjesy et al., 2007). A. vaginae is an 
anaerobic Gram-positive, as G. vaginalis, is found in more than 95% of BV, but is also 
present in normal flora of the vagina of healthy women (Ferris et al., 2007). 
1.3.2. BV-associated bacteria 
 G. vaginalis is a Gram-variable bacterium, which was first described in 1953 by 
Leopold, and has been identified as the predominant BV. The name Haemophilus 
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vaginalis was originally proposed by Gardner and Dukes in 1955, due to the colony 
morphology of the organism and its biochemical profile. Subsequently, metabolic 
requirements and thorough analysis of preparations using Gram staining, it was found that 
the organism morphologically resembled bacilli diphtheroids and named 
Corynebacterium vaginale (Greenwood et al., 1979). However, due to their variable 
Gram staining reaction (not being positive or negative typically) was subsequently named 
Gardnerella (Figure 1.4). 
 
 
 
 
Figure 1.4. a) Epithelial cell totally covered by Gram-positive bacteria (clue cell), G. vaginalis. Source: 
http://farm3.static.flickr.com/2056/2369779554_f4d9b48760_z.jpg, accessed August 1, (2012); b) Gram 
staining of Gram-variable G. vaginalis AMD bacterium that we prepared (original magnification, x1000).  
Gardnerella belongs to the Bifidobacteriaceae family, and their cells are small, 
pleomorphic bacilli (Figure 1.5) in which the length and Gram stain may vary depending 
on the growth medium (Catlin, 1992). 
 
 
 
Figure 1.5. Scanning electron microscope (SEM) of G. vaginalis biofilm. Source: 
http://www.gardnerella.mic.vcu.edu/images/gv_em.jpg, accessed August 1, (2012). 
G. vaginalis is considered a fastidious and anaerobic microorganism that requires 
a complex growth medium (Harwich et al., 2010). Studies of microorganism 
identification using metabolic methods indicate that it is a catalase-negative 
microorganism, exhibits activity α-glucosidase, hydrolysis of starch and hippurate, acid 
phosphatase activity, salt tolerance and can use carbohydrates such as dextrins, fructose, 
a) b) 
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glucose, maltose, ribose, starch and sucrose from fermentation for growth (Catlin, 1992; 
Harwich et al., 2010). 
Researchers such as Gardner and Dukes identified this bacterium as a major 
etiologic agent of BV, fulfilling all the Koch's postulates (Table 1.3). However, later 
studies demonstrated some failures in these experiments which suggested that there were 
other factors in addition to G. vaginalis that were important in the induction of the 
disease, meaning that these bacteria were not the etiologic agent in BV. One of the Koch's 
postulates requires pathogenic microorganisms to be found in all cases of the disease and 
not be found in individuals who do not have the disease (Evans, 1993). In the case of G. 
vaginalis, it was found in many cases of BV, but can also detected in 50 - 60% of women 
who have no visible symptoms of BV, thus failing one of Koch’s postulates (Fredricks 
and Relman, 1996). 
Table 1.3. Koch´s postulates. Adapted from Evans, (1993). 
 
 
 
 
 
 
 
 
The role of G. vaginalis in BV has been extensively debated since it can be both 
present in the genital tract of healthy women (Hyman et al., 2005) as in women with BV. 
However, vaginal epithelial tissue of women with BV presents a larger number of 
anaerobic microorganisms (Swidsinski et al., 2005). Moreover, recent studies show that 
the biotypes of G. vaginalis isolates from healthy women differ from those isolated from 
women with BV (Numanovic et al., 2008). The lack of genetic characterization of this 
microorganism leaves open the possibility that different pathogenic and nonpathogenic 
strains or subspecies exists (Harwich et al., 2010). 
The discovery of the presence of A. vaginae in the vaginal ecosystem improves 
the basic understanding of the pathogenesis of BV (Polatti, 2012). The bacterium A. 
The etiologic microbe should be found in every case of the disease 
 
The etiologic microbe should not be found in subjects without disease 
(specificity) 
 
The etiologic microbe should be isolated in pure culture on lifeless media and be 
capable of causing the characteristic disease anew upon inoculation in a 
susceptible host 
 
The etiologic microbe should be reisolated from the experimentally inoculated 
host 
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vaginae belong to the family Coriobacteriaceae. It is thought that this newly identified 
bacterium is one of the causes of complications that arise in BV (Fredricks et al., 2005). 
The genus Atopobium was described for the first time in 1992, and includes bacteria 
previously classified as lactobacilli (Rodriguez et al., 1999). Relatively to morphology, 
Gram stain shows varied morphology, as their cells appear as Gram-positive elliptical 
cocci or rod-shaped organisms and can be visible as single cells, in pairs or in short 
chains (Figure 1.6). A. vaginae is an anaerobic bacteria, that cannot be easily isolated by 
classical microbiological methods and it is rarely detected in healthy women vaginal fluid 
but is commonly found in the vagina of patients with BV (Verhelst et al., 2004). 
 
 
 
 
 
Figure 1.6. Gram staining shows Gram-positive bacteria, with A. vaginae visible as single cells, in pair or 
short chains. Adapted from Geißdörfer et al., (2003). 
Mobiluncus spp. is another anaerobic organism most commonly associated with 
BV. These fastidious curved rods are only rarely cultured from vaginal smears of women 
without BV, yet are highly predictive of BV if found on Gram stain or wet-preparation 
examination of vaginal secretions (Thomason et al., 1984) (Figure 1.7). 
 
 
 
 
 
Figure 1.7. Gram staining of vaginal smear of clinical sample that we received shows curved rods, 
morphotypes associated with Mobilluncus spp. (original magnification, x1000). 
The presence of Mobiluncus spp., specially M. curtisii and M. mulieris is highly 
specific, although not sensitive, for the diagnosis of BV (Roberts et al., 1985). The 
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presence and persistence of M. curtisii, detected by Polymerase Chain Reaction (PCR), 
was found to be strongly associated with recurrence of BV. Whether this organism is 
truly pathogenic or simply a marker for greater disturbances of vaginal flora remains 
unknown (Meltzer et al., 2008). 
To better understand BV there is a need to isolate more BV-associated bacteria, 
such as the species detected by molecular methods (Table 1.4). 
Table 1.4. Detailed composition of the vaginal microflora of 515 vaginal swab samples, as determined by 
culture and tDNA intergenic spacer PCR (tDNA-PCR) based identification. Adapted from Verhelst et al., 
(2005). 
 
Bacterial vaginosis-related anaerobe organisms 
 
Actinomyces neuii 
 
Gemella morbillorium
b 
Aerococcus christensenii Mobiluncus curtisii 
Anaerococcus tetradius
b Mycoplasma hominis 
Anaerococcus vaginalis
b Peptoniphilus spicies.b 
Atopobium vaginae Peptostreptococcus sp. 
Bacteroides ureolyticus Prevotella bivia 
Dialister species Prevotella ruminicola 
Finegoldia magna
b Prevotella species 
Gardnerella vaginalis Varibaculum cambriense 
 
b Formerly known as Peptostreptococcus  
 
 
1.4. Vaginal microbial diversity 
1.4.1. Isolation - Culture perspective 
Culture studies provide critical results on the phenotypic characteristics of the 
microorganisms that are not easily obtained from molecular studies. Moreover, a 
microorganism culture allows manipulation of these organisms in experimental laboratory 
and testing hypotheses about their pathogenesis and virulence factors. Thus, studies using 
the culture of microorganisms remain an important area of research in vaginal 
microbiology, despite the limitations of this approach (Donachie et al., 2007).  
Burton and Reid published a study which involved the isolation of the 
microorganisms in culture using selective and non-selective media and subsequent 
identification by phenotypic techniques. The use of a wide range of PCR primers helped 
to maximize the diversity of species detected and a large number of media and growth 
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conditions may be required for optimal isolation of diverse bacterial species (Burton and 
Reid, 2002). Selective media such as MacConkey agar, mannitol and Tryptic Soy Agar 
(TSA) with 5% sheep blood may be useful to estimate the number of aerobic and 
anaerobic bacteria in vaginal samples. Some of the selective media/ semi-selective agar 
include Rugosa, De Man-Rugosa and Sharpe (MRS) agar and Human bilayer Tween 
(HBT) and Columbia Blood Agar (CBA) with 5% horse blood are used to help identify 
microorganisms presents in vaginal swabs samples (Figure 1.8). In some of the media, 
such as the CBA it is possible to observe the hemolysis arising from the growth of some 
microorganism (eg. bacterium G. vaginalis shows β-hemolysis in CBA) (Totten et al., 
1982). 
 
 
 
Figure 1.8. Growth of the bacterium G. vaginalis AMD in CBA selective medium.  
 Thus, using approaches based on the culture of organisms, it is possible to identify 
G. vaginalis and anaerobic bacteria such as Neiserria gonorrhea, Streptococcus spp., 
Escherichia coli, Trichomonas vaginalis, Prevotella, Porphyromonas, 
Peptostreptococcus, Mobiluncus and Mycoplasma, which may be largely associated with 
disturbances in the microbial flora in women with BV (Kalra et al., 2007). 
1.4.2. Isolation - Molecular Perspective 
 Results of different research groups confirmed that the human vagina hosts 
numerous species of bacteria which are not yet cultured or are not easily identified by 
culture methods (Srinivasan and Fredericks, 2008). 
 With advances in technology and decreasing costs of sequencing, there is a better 
knowledge of the microflora of the human vagina. As the conditions of the vagina may be 
transient and dependent on many factors, molecular studies provide results able to 
demonstrate features of the vaginal microbiota under specific conditions (Hugenholtz et 
al., 1998). 
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 Burton and Reid, were also the first researchers to examine the microbiota of the 
vaginal niche using a wide range of molecular methods such as PCR and Denaturing 
Gradient Gel Electrophoresis (DGGE) and found that different women with BV had 
different profiles indicating heterogeneity in bacterial composition in subjects with BV 
(Burton and Reid, 2002). Many researchers such as Verhelst et al., (2004), Fredericks et 
al., (2005), contributed to the current knowledge of BV, and there are many studies that 
have been performed in order to intensively investigate the bacterial flora of the human 
vagina. These studies, using methods of cultivation and molecular approaches aimed to 
reveal which microorganisms are the most persistent in BV. 
 Although progress has occurred in defining the composition of vaginal flora using 
Deoxyribonucleic acid (DNA) amplification, the rapid accumulation of data resulted in no 
therapeutic advantage. Treatment options remain limited and often have unsatisfactory 
results, especially in relation to the frequent relapse of symptomatic disease, leading to 
great frustration among patients and professionals (Srinivasan and Fredericks, 2008). 
1.4.3. Virulence factors of G. vaginalis 
 The normal flora of the human vagina is a diverse set of microorganisms that live 
in a dynamic relationship in the colonized epithelium. Although the colonization of the 
lower female genital tract is usually benign, it is noted that the vast majority of infections 
involving female pelvic structures arise from organisms that are members of the normal 
flora (Larsen, 1994) due to a shift in the microbial balance caused by reasons discussed 
previously. 
 Although there is much controversy surrounding the etiology of BV, G. vaginalis 
remains the most studied organism and potential primary agent of BV. The following 
factors its pathogenic potential. 
1.4.3.1. Initial adhesion to epithelium 
 Microorganisms can improve their virulence factors by producing compounds 
which act against host defense or in response to them. This virulence attributes include: 
interacting with the host defense, adhesion to host tissue, adjustment of the characteristics 
of virulence and production of toxins (Larsen, 1994). The organism adhesion to the 
epithelial surface is a significant aspect in the life of microorganisms in the vagina. The 
bacterium G. vaginalis, which is present in asymptomatic women and in abundance in 
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individuals with BV, is known for its ability to adhere to epithelial cells (Patterson et al., 
2010). Boustouller et al. attribute the responsibility of adhering to the epithelial cells to 
pilli, while Scott and Smyth believe that the fibrillar matrix is responsible for foreign 
citoadhesion, with pilli functioning as a hemagglutinin (Scott and Smyth, 1987; 
Boustouller et al., 1989). It should be considered that although cell adhesion is important 
in the disease process, the fixation to the tissue does not characterize an organism as 
pathogenic. In fact, vaginal lactobacilli have adhesins that probably serve to promote the 
stable colonization of the vaginal epithelium, possibly with beneficial effects for the host 
(Nagy et al., 1992). Thus, if a microbial species is a highly virulent or only modestly 
virulent it is due to the interaction with the host tissue through adhesives factors. 
 Clearly, organisms that are usually associated with the host, described as 
belonging to the normal commensal flora have had little attention as producers of toxins. 
Although, the production of toxins with subtle effects on the physiology of the host, or his 
immunity, may play a role in the virulence of this microorganism (Larsen, 1994). 
1.4.3.2. Cytotoxicity of G. vaginalis 
 While G. vaginalis can be isolated in 95% of cases of BV, studies with healthy 
subjects indicate that pure cultures of bacteria do not always cause BV, perpetuating the 
exiting doubts about it is potential as a pathogen (Catlin, 1992; Marrazzo et al., 2008). 
However, the connection between the cytolysin secreted by G. vaginalis, called recently 
vaginolysin (VLY), and BV has been made (Gelber et al., 2008). The production of the 
cytolysin by G. vaginalis was first reported in 1990 but was only recently named VLY. 
VLY, a cholesterol-dependent cytolysin recognizes the complement of the molecule 
CD59 on the target cell surface, which accounts for the specificity for human erythrocytes 
epithelial cells (Madden et al., 2001), leading to cell death (Gelber et al., 2008). 
Immunoglobulin A (IgA) antibodies against VLY have been linked to the mucosal 
immune response during BV, increasing the emphasis on the role of VLY in the 
pathogenesis of BV (Cauci et al., 2002). Studies have examined the levels of cytotoxic 
activity of anaerobes associated with BV, and found that only the bacteria G. vaginalis 
was able to induce lysis of vaginal epithelial cells (Patterson et al., 2010). 
 Other virulence factors produced by G. vaginalis include sialidase and prolidase, 
which are two hydrolytic enzymes that may play a role in the degradation of many 
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mucosa protective factors, such as mucins and contribute to the detachment and 
exfoliation of epithelial cells (Cauci et al., 2008). 
1.4.3.3. Formation of biofilm 
 The adherence to the epithelium is the first step in the pathogenesis of a biofilm-
forming pathogen as it must first adhere to host tissues in order to avoid the clearance by 
means of host defense mechanisms, such as urine flow and the flow of vaginal secretions, 
and be able to form a biofilm (Patterson et al., 2010). Biofilm formation is an important 
virulence factor because it confers tolerance to antibiotics (Figure 1.9) and increased 
resistance to host immune defense (Cantón et al., 2005). 
 
 
 
 
 
 
 
 
 
Figure 1.9. Proposed mechanisms for antibiotic resistance of biofilms. Yellow region: is characterized by 
low penetration, the antibiotic (yellow) may fail to penetrate the surface layers of the biofilm. Green region: 
some of the bacteria can differentiate themselves to protect the phenotypic state (green). Red region is in 
regions of lack of nutrients or accumulation of waste products (red), the action of the antibiotic can be 
antagonized. Adapted from Stewart and Costerton, (2001). 
 Microbial biofilms are communities of microorganisms that are closely associated 
with each other in a way that they are attached to a surface, in this case to vaginal 
epithelial cells, forming a porous structure where the microbial cells are involved in 
extracellular matrix polymers and are able to concentrate products of their own 
Antibiotic (yellow) may 
fail to penetrate beyond 
the surface layers of  
the biofilm 
Some of the bacteria 
may differentiate into 
a protect phenotypic 
state (green) 
In zones of nutrient 
depletion or waste product 
accumulation (red), 
antibiotic action may be 
antagonized 
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metabolism, together with ions and nutrients that are captured from the environment that 
surrounds them (Costerton, 1995). This matrix consists of several components including 
proteins, extracellular polysaccharides (EPS), nucleic acids and other substances (Davey 
and O´toole, 2000) and represents approximately 85% of the biofilm (Donland and 
Costerton, 2002). The synthesis of polymer matrix appears to be regulated by a variety of 
factors in which the cell surface adhesion is very important. The exopolymers serve two 
main functions within the biofilm: first, the polysaccharides are produced in large 
amounts after initial fixation of the cell surface, being suggested to act as ―cement‖ with 
which bacteria can reinforce the primary mechanisms of adhesion (Figure 1.10). Then, 
due to the existence of an extracellular polymer matrix (Gilbert et al., 1997) bacteria 
become protected against biocides, antibiotics and surfactants, by limiting diffusion of the 
agents of the surrounding medium through a combination of ionic interactions and 
molecular events, and are also protected from bacteriophages and other phagocytic 
predators such as protozoa (Dunne, 2002). Biofilms can release antigens and stimulate 
production of antibodies, but the bacteria living in biofilms are generally resistant to these 
defense mechanisms, providing the basis for persistent infections (Costerton, 1995). The 
microenvironment generated allows a symbiotic relationship of the species that make up 
the biofilm, providing necessary nutrients and allowing in some cases, due to the close 
proximity between different species involved, the transmission of genetic elements 
(Roberts et al., 1999). 
 Biofilms can be composed of populations derived from a single species or a 
community of diverse species but, in both cases, the development of biofilm behavior 
requires the multistage approach described above (Davey and O´Toole, 2000). Biofilm 
formation and its structure are affected by many conditions such as surface properties, 
nutrient availability, hydrodynamics and microbial community (Davey and O´Toole, 
2000). The biofilm cells have different metabolic activities, depending on their position 
within the biofilm and can change over time. 
 Many species have been shown to use the same steps in biofilm formation, which 
include 1) an initial adhesion to the surface, 2) formation of the microcolonies 3) ripening 
microcolonies in the developing matrix thereby allowing the maturation of biofilm and 4) 
dispersion of planktonic bacteria (Figure 1.10). It is believed that the biofilm formation 
bacteria start when certain environmental factors trigger the fluctuations in cell-
population density (Miller and Bassler, 2001) through a mechanism called quorum 
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sensing (O´Toole et al., 2000). Since these communities are dynamic, there is also a great 
exchange of information through the mechanism of quorum sensing, which allows them 
to better adapt their phenotype and gene expression to changes in the surrounding 
environment. Many bacteria use this mechanism to regulate a diverse array of 
physiological activities (Miller and Bassler, 2001). 
 
 
 
 
 
 
 
 
 
Figure 1.10. Schematic representation of the stages of microbial biofilm forming multiple bacteria 
development. The progression of biofilm, initiated with bacterial contamination, followed by colonization, 
leading to critical colonization and systemic infection. Adapted from Phillips et al., (2008). 
In fact, direct evidence of microscopic analysis of biopsies performed on women 
with BV revealed the presence of bacterial biofilm on the vaginal epithelium (Swidsinski 
et al., 2005), and examining the composition and structural organization of the vaginal 
biofilm, has revealed that G. vaginalis accounted for 60 - 95% of the biofilm mass, A. 
vaginae accounted for the 1 - 40% of the biofilm mass whereas Lactobacillus maked up 
only 5% of the biofilm (Polatti, 2012). Studies using therapeutic treatments, like the 
antimicrobial agent metronidazole, revealed that biofilm formation is a decisive factor in 
the virulence of BV as it could not act in biofilm leading to relapse (Polatti, 2012). 
Because microorganisms in biofilms react differently to antibiotic treatment when 
compared with their planktonic counter-parts (Fux et al., 2005), antibiotic resistance is 
postulated as one of the reasons for persistent and recurrent BV (Polatti, 2012). 
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 In vitro experiments show that G. vaginalis has a propensity to form biofilm 
(Figure 1.11). Patterson et al., (2010) reported to presence of a protein associated with 
biofilm homologous to other biofilm-associated proteins (BAP) and BV. In G. vaginalis 
isolates the gene identified by Patterson et al., (2010), is called by Bapl - Like (BapL). 
BAP are large proteins, which are anchored to the cell wall with the capacity to mediate 
adherence to host cells and intracellular adhesion, thus contributing to biofilm formation 
(Latasa et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11. Biofilms formation of strains of G. vaginalis and anaerobic bacteria associated with BV. a) 
Bacteria were grown anaerobically in Brain Heart Infusion Broth supplemented with glucose (sBHIG) at 
37°C for 24 h. The adhered cells were stained with safranin; b) Quantitative assessment of the capability of 
formation of the biofilm formation was made by dissolving safranin stain in 33% acetic acid and measuring 
optical density (OD) OD562. Adapted from Patterson et al., (2010). 
 Summarizing, there is strong evidence that G. vaginalis has an innate pathogenic 
potential compared to other BV-associated anaerobes. However there may still be many 
virulence factors not yet described, or maybe G. vaginalis has the potential of becoming 
more pathogenic in the presence of other species. It is also likely that the main agent of 
BV, if any, varies from case to case, however, several studies suggest that due to the 
many factors of virulence present in G. vaginalis, it is likely that the key agent in certain 
cases of BV is this bacterial species. 
b) a) 
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1.5. Outline and objectives of this thesis  
 In one study publish this year it was shown that BV is a prevalent gynaecological 
disorder in Portugal and that additional studies should be done to better characterize it in 
epidemiological and microbiological terms (Henriques et al., 2012). Thus, the 
characterization of vaginal microflora is a very important tool for the understanding of the 
vaginal flora associated with BV and can help investigate the significance of this 
condition in clinical pathology and to guide treatment (Srinivasan and Fredericks, 2008).  
The main objective of this thesis is the study of clinical vaginal swab samples of 
Portuguese patients healthy or with BV. For this, this thesis is divided into 4 chapters. 
The first includes a general introduction to the work and includes the major implications 
and treatment of this condition. The methods, results and their discussion are separated 
into different sections, each one corresponding to a part of the experimental work. 
Chapter 2 concerns the studies of isolation the G. vaginalis and others microorganisms 
belonging to the vaginal flora, followed by characterization of the biofilm formation 
capacity and susceptibility of these strains by determining the MIC in chapter 3. The last 
chapter outlines the main conclusions and suggestions for future work. 
 Knowing more about how bacterial communities in the human vagina promoting 
health or facilitate disease is important, in order to optimize reproductive health. 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2  
Isolation and identification of microorganisms from clinical 
vaginal samples 
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2.1. Introduction 
The identity and diversity of populations of vaginal microflora remains largely 
obscure and the complex interactions of the various members of the vaginal flora are 
still poorly understood. However, as described in chapter 1, in recent years several new 
fastidious bacteria have been identified that show a high specificity for BV (Fethers et 
al., 2012). These microorganisms have been evaluated using cultivation-dependent 
methods of vaginal fluid samples and it was observed that most species require special 
conditions of culture media and incubation. Traditional methods of biochemical 
characterization such as oxidase, catalase reactions and Gram staining allow the 
identification of various microorganisms but fail to identify many vaginal 
microorganisms (Ledger and Witkin, 2007). On the other hand, recently, molecular 
biology techniques (cultivation-independent) have provided new insights regarding 
bacterial diversity in vaginal flora, particularly in women with BV (Zhou et al., 2004). 
What is currently accepted is that healthy women are mainly colonized by lactobacilli, 
though a variety of other bacteria may be present in BV (Fethers et al., 2012). 
2.2. Objectives 
The main objectives of the work described in this chapter were the isolation and 
identification of microorganisms from clinical vaginal samples in women with or 
without BV. The isolation of these microorganisms was necessary to enable phenotypic 
characterization of selected isolates in the next chapter of this thesis. 
2.3. Materials and Methods 
2.3.1. Study population and sample collection 
The collection of clinical vaginal samples from patients with suspected BV and 
healthy vaginal flora was performed with the collaboration of some Portuguese 
gynecologists who performed the collections at their private clinics. All volunteers were 
asked to complete a questionnaire form which data was analyzed by another member of 
our research group (Salgueiro, 2012) and clinically examined. The doctors proceeded to 
the collection of the samples using an unlubricated sterile swab with Amies transport 
medium provided with coal (VWR) (Al-Muk and Hasony, 2001). The swabs were 
transported, within 48 h of collection, to the laboratory. As soon as the clinical samples 
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arrived at the Laboratory of Applied Microbiology 1 (LAM 1), of the Department of 
Biological Engineering, University of Minho, they were processed (Kharsany et al., 
1993). 
 
2.3.2. Treatment of the clinical samples 
Each sample was used to make a smear for Gram stain (as described in section 
2.3.3.2) and the evaluation of vaginal microflora of each patient and BV diagnosis were 
based on the method described by Nugent et al., (1991). After this, each sample was 
placed in selective culture media (as described in 2.3.3.1) and the swab was inserted 
into a plastic tube containing 2 ml of sterile saline solution of 0.9% sodium chloride 
(NaCl) (ProLAbo) which was vortexed vigorously until the solution becomes cloudy, so 
as to recover all the bacterial cells still present in the swab. Then, 1 mL was transferred 
into 2 eppendorfs, and centrifuged at 10,000 rpm for 5 min. At the end, the supernatant 
was discarded leaving only the pellet in eppendorfs (BIOplastics); one of them was used 
to prepare suspensions to be used for PCR (for selection of positive samples for G. 
vaginalis, as described in 2.3.3.3) by resuspending the pellet in ultra-pure water and the 
remaining pellet was used to prepare a cryovial containing the pellet resuspended in 800 
µL of Brain Heart Infusion (BHI) broth (Oxoid) with 200 µL of pure sterile glycerol 
(Panreac) (final concentration of glycerol 20%). All samples were then stored in 
cryovials (VWR) properly identified and stored at -80°C. The cryopreservation of 
samples allows the preservation of the genotypic and phenotypic characteristics of 
bacteria, ensuring that the characteristics remain intact for further studies, decreasing 
the risk of bacterial contamination or fungal. 
 
2.3.3. Isolation and identification methods 
2.3.3.1. Culture methods 
Media and growth conditions 
Selected samples were cultured on Columbia Blood Agar Base (CBA) 
(Liofilchem) supplemented with 5% of defibrinated horse´s blood (Probiologica) with 
G. vaginalis selective supplement (Oxoid) or CBA without supplement; Man-Rogosa 
and Sharpe Agar (MRS) (Liofilchem) that were prepared according to the 
manufacturer´s instructions and Bromocresol Purple Starch Agar (Purple) which is 
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composed by 7.5 g/L of Peptone from Meat Peptic Digest (Merck); 7.5 g/L of Tryptone 
(Liofilchem); 1 g of Corn Starch from Potato (Pancreatic); 4 g/L of Dipotassium 
Phosphate (K2HPO4) (Panreac); 1 g/L of Monopotassium Phosphate (KH2PO4) 
(Panreac); 5 g/L of NaCl (ProLabo); 12 g/L of Agar (FisherScientific); 10 g/L of Starch 
soluble (FisherScientific); 0,0096 g/L of Bomocresol Purple (Acros-organics) and in the 
end of sterilization (121ºC for 15 min), after cooling, 30 µg/mL of Nalidixic Acid 
(Biochemica) (5 mg/mL) was added to the Purple agar. Plates (Frilabo) were incubated 
in 10% carbon dioxide (CO2) for 72 h at 37ºC in anaerobic environment. 
 
2.3.3.2. Isolation and identification of bacterial isolates 
After growth of the samples on a selective culture medium growth, the colony 
morphologies were analyzed in order to proceed to the isolation and identification of 
microorganisms in each selected vaginal swabs. Once isolated strains were obtained 
they were characterized according to colony morphology, Gram staining, and 
biochemical tests such as oxidase and catalase tests (Forbes et al., 2007), as described 
below. 
We analyzed the growth of each of the samples in different growth media and 
isolated the different colonies observed in their respective growth media, using the 
microbial streaking technique (Figure 2.1). Typically pure cultures were obtained by the 
2
nd
 generation. If by the 2
nd
 generation we still did not have isolated strains, a 
suspension of the mixed cultures was used and serial decimal dilutions in 0.9% saline 
solution of NaCl were performed and plated in an agar plate, divided into eight 
quadrants and 5 µl of each dilution placed in the respective quadrants. In subsequent 
generations isolated colonies were obtained. To confirm the isolation Gram staining, 
oxidase, catalase and PCR were performed. Finally, the 16S gene was sequenced, as 
described below on section 2.3.3.3. 
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Figure 2.1. Method of making a streak plate to obtain pure cultures. a) Loop is flame-sterilized, and then 
a loopful of one colony is removed from plate. Streak is made over a sterile agar plate, spreading out the 
microorganisms. Following the initial streak, subsequent streaks are made at angles to it, the loop being 
re-sterilized with heat between streaks. Adapted from Seeley, Seeley et al., (1991); b) Colonies of the 
bacterium G. vaginalis 5-1 grown on CBA plates. This bacterium was isolated by Patterson et al., (2010) 
from women without BV as diagnosed by the Nugent Gram stain scoring system. 
Gram stain 
Gram staining was performed in two occasions: when the samples arrived a 
smear (from the original sample); and when the isolation of microorganisms was 
finished to make sure it was pure culture. In both cases, the fixation step was performed 
using heat holding the swab over a flame until all the water evaporated. Staining was 
done in several steps: 1) the swab was covered with crystal violet (primary dye) 
(AppliChem) with gentle shaking for 60 seconds; 2) sample was washed with water; 3) 
the smear was covered with Lugol´s solution iodine (AppliChem) leaving to react for 60 
s, forming a complex with crystal violet; 4) sample was washed with water; 5) the 
smear was then covered with alcohol 70% (bleaching agent), stirring gently for 60 s; 6) 
Finally, the sample was covered with safranin solution (Liofilchem) for 30 s, and finally 
washed and dried with filter paper. At the end of the Gram staining, smears were 
observed using a light microscope, in order to characterize the Gram staining reaction 
(positive = purple or negative = pink) and noting their morphology. Controls were used 
for each individual display; negative Gram stain reaction control - Escherichia coli 
(Turovskiy et al., 1991) and as positive Gram stain reaction control Staphylococcus 
epidermidis (Rowlinson et al., 2006) (Figure 2.2). 
 
a) 
Isolated 
colonies at end 
of streak 
Confluent growth 
at beginning of 
streak 
b) 
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Figure 2.2. Gram staining of isolates that we prepared (original magnification, x1000). Gram stain 
showing a) Gram-positive (purple) Staphylococcus epidermidis bacterium; b) Gram-negative (pink) 
Escherichia coli bacterium. 
Biochemical tests 
Single colonies of all microorganisms obtained from the isolation procedure 
were typed, using 2 biochemical tests: oxidase and catalase test.  
Oxidase test: The oxidase test is used in microbiology to determine whether a 
bacterium produces cytochrome c oxidase (Jurtshuk and Liu, 1983). For this, oxidase 
strips (Oxoid) containing NNN'N'-tetramethyl-p-phenylene-diamine dihydrochloride 
(TMPD) were used. This reagent turns dark blue when oxidized and colorless when 
reduced. When it comes in contact with oxidase-positive bacteria that have indophenol 
oxidase or cytochrome oxidase the indicator strip turns blue (Isenberg, 2004). On each 
strip a small portion of the test biomass was added and observed after 20 s. If the area of 
inoculation turns dark blue to brown then the result is positive. If the color does not 
change within the allotted time, the result is negative. The control strains used in this 
test were, as a positive control Pseudomonas aeruginosa and as negative control E. coli 
(Gaby and Hadley, 1957). 
Catalase test: To perform the catalase test, a drop of H2O2 was added onto a 
microscope slide, using a sterile loop. Then, a small portion of the biomass to be 
analyzed is added and mixed. A positive catalase reaction was obtained when there was 
immediate release of oxygen (bubbles formed), which indicated the catalase activity 
(catalase acting on H2O2, water (H2O) and releasing oxygen (O2) according to the 
following reaction: H2O2 → 2 H2O + O2). Controls were used for the catalase reaction 
a) b) 
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negative control G. vaginalis AMD (Aroutcheva et al., 2001) and as positive control S. 
epidermidis (Rowlinson et al., 2006). 
2.3.3.3. Molecular methods 
Polymerase Chain Reaction (PCR) 
The suspensions made for PCR from initial clinical samples, were treated with a 
thermal shock in order to break the cell wall and facilitating the release of DNA for the 
PCR reaction. To achieve this, samples were incubated for 15 minutes in a heating 
block at 100°C. After completing the incubation at 100°C, samples were immediately 
incubated on ice for at least 5 min. A master mix was prepared for the PCR reaction for 
n + 1 samples (where ―n‖ is the number of samples to be tested) for each of 
combinations of primers to be used. Each PCR reaction (final volume of 10 µL) 
required 5 µL PCR 2x mix conc. (DyNazyme Master Mix: Finnzymes), 0.5 µL forward 
(Fw) primer, 0.5 µL reverse (Rv) primer, 0.5 µL sample (directly added to each tube 
and not to PCR master mix) and 3.5 µL of ultra-pure water. After the master mix was 
prepared, 0.5 µL of the samples were added to the respective PCR tubes and then 9.5 
µL of master mix was added to each PCR tube. The specific primers used to identify G. 
vaginalis, Lactobacillus spp. or A. vaginae are described in table 2.1.The tubes were 
placed on a thermocycler (BioRad) and a thermocycling program was selected 
consisting on the following steps: 94°C for 2 min, 94°C for 30 s, 51°C for 30 s, 72°C 
for 40 s, repeat the step 2, 44 times, 72°C for 5 min and 4°C for ∞.   
 
Gel Electrophoresis 
PCR products were loaded on to an agarose gel which consisted of 1% (w/v) 
agarose in 1x Tris-acetate-EDTA (TAE) buffer. The agarose solution was heated in a 
microwave oven and then allowed to cool before adding 0.04 µL/mL of Midori Green 
DNA stain (Nippon Genetics Europe). Then, the mold was prepared with the desired 
comb and the agarose solution was poured into the mold. Once polymerized the gel was 
placed in the electrophoresis tank containing 1x TAE buffer and the comb removed, 
making sure that the wells were completely covered by the buffer. Before loading the 
samples on agarose gel, 1 µL of loading buffer was added to each PCR reaction (this 
turned the sample blue thus facilitating the loading of agarose gels; makes the sample 
settle at the bottom of the well). The samples were loaded onto the gel as well as the 
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DNA ladder (FastRuler Middle Range DNA Ladder - Fermentas). Finally the gel was 
run in the electrophoresis tank at 100 volts for 30 min and the results were visualized 
using the ChemiDoc (BioRad) system according to manufacturer's instructions.  
The samples that tested positive for G. vaginalis of clinical samples (with and 
without BV) were selected for the isolation of the microorganisms, as described in 
section 2.3.3.2. 
Table 2.1. Primer sequences used for the PCR assays used in this study. 
 
Bacterial identification by sequencing of 16S ribosomal DNA 
PCR for Sequencing 
The vaginal isolates presenting different characteristics such as colony 
morphology, and where Gram stains revealed pure cultures were selected and a single 
colony picked to perform PCR for production of fragments using universal primers to 
increase the amount of bacterial 16S ribosomal DNA (rDNA) sequences for the 
purposes of sequencing (Fw 5 'GTT TGA TCC AGA TGG CTC AG 3 '; Rv 5' CCA 
GGA ATC GGG CTA TAT TAA 3 ') (Wilson et al., 1990). The PCR protocol used is 
similar to that already described, but differed in some points. For each PCR reaction 
(final volume = 60 µL) was necessary to use 30 µL master mix (Phusion High-Fidelity 
PCR Master Mix, Finnzymes), 4 µL primers (Fw + Rv), 4 µL template (directly added 
to each tube and not to PCR master mix), 22 µL H2O of ultra-pure water. The tubes 
were placed on a thermocycler (BioRad) with a thermocycling program which consisted 
of the following steps: 98°C for 2 min, 98°C for 10 s, 51°C for 30 s, 72°C for 30 s, 
repeat the step 2, 35 times, 72°C for 30 s and 4°C for ∞. The results of the PCR reaction 
Target Primer/ Probe PCR conditions Primer/ Probe Sequence (5´- 3´) References 
G. vaginalis Gard 154-454 60ºC annealing, 30 s 
72ºC extension, 30 s 
Fw  CTCTTGGAAACGGGTGGTAA  
Rv  TTGCTCCCAATCAAAAGCGGT 
(Magalhães 
et al., 2011) 
A. vaginae Atop 167-715 60ºC annealing, 30 s 
72ºC extension, 30 s 
Fw  GCGAATATGGGAAAGCTCCG 
Rv  TCATGGCCCAGAAGACCGCC 
(Pepin et 
al., 2011) 
Lactobacillus spp. New Lacto 62ºC annealing, 30 s 
72ºC extension, 30 s 
Fw  TGGAAACAGRTGCTAATACCG 
Rv  GTCCATTGTGGAAGATTCCC 
(Byun et al., 
2004) 
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was visualized using gel electrophoresis as described before using a total volume of 
PCR product of 10 µL.   
The PCR products amplified by the universal primers were further purified using 
a kit GeneJET PCR Purification Kit (Fermentas), according to manufacturer's 
instructions (GeneJET PCR purification Kit, 2012). The purified PCR products were 
sent along with the reverse primer to the company Eurofins MWG Operon (Germany) 
for sequencing. 
Analysis of the nucleotide sequences amplified by PCR and sequenced by 
Eurofins was performed using the software Basic Local Alignment Search Tool 
(BLAST). The BLAST database, 16S ribosomal Ribonucleic acid (rRNA) gene 
sequences (Bacteria and Archaea) (available http://blast.ncbi.nlm.nih.gov/Blast.cgi), 
allows investigation of the nucleotide sequences obtained considering the homology 
contained in this database of the National Center for Biotechnology Information 
(NCBI), allowing the determination of the statistical significance of the matches.  
2.4. Results and discussion 
2.4.1. The importance of the vaginal microflora characterization 
Molecular techniques have been shown to be very important in diagnosis of 
infectious diseases, promoting fast identification of clinically relevant microorganisms 
in BV.  Over the years, many attempts have been made to improve traditional and 
molecular techniques in order to learn more about the human vaginal flora. Their 
characterization is an important step at understanding the pattern of flora associated 
with BV that is typically characterized by the replacement of normal vaginal microflora 
of lactobacilli by G. vaginalis and other anaerobic microorganisms. Unfortunately, 
much of what is known about the human vagina microbial flora is due to qualitative and 
descriptive studies that relied on the characterization of bacterial populations easily 
cultivable (Marrazzo et al., 2002). The technical limitations associated with classical 
microbiological culture techniques have unwittingly affected the ability of clinicians to 
understand the etiology of this clinical condition (Zhou et al., 2004). 
The main objective of this study was the isolation and characterization of 
microorganisms belonging to the vaginal flora.  The main problem faced in the isolation 
of some microorganism’s lies with the fact that they have a fastidious growth and can 
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lose viability very easily, as described in chapter 1. The isolation procedure was 
optimized, as described in section 2.3.3.2 of Materials and Methods.  We were able to 
adjust the isolation procedure, and confirm isolates identity by doing Gram stain, 
biochemical tests and sending isolates for sequencing of the 16S rRNA gene in order to 
obtain the identity of isolates (Table 2.4). With the sequencing results it was possible to 
make an accurate identification of isolated microorganisms. This was important because 
although the biochemical tests, Gram staining, growth conditions and other tests allow 
us to reach some conclusions and provide information about each of the 
microorganisms isolated, these traditional techniques do not provide enough 
information to allow us to reach firm conclusions about the true identity of the 
microorganisms. There were organisms recovered with the same characteristics in terms 
of cultivability and cellular composition, which yielded similar results with the 
biochemical tests used. All microorganisms isolated in this study are shown in table 2.2 
and 2.3. 
 
2.4.2. Isolation and identification of vaginal isolates 
We received 54 clinical samples, but only 8 samples were positive for G. 
vaginalis, as determined by PCR, and only these samples were selected to be cultured. 
As such, we studied the composition of the vaginal microflora of those 8 clinical 
vaginal samples. Some came from women with BV and others from women which 
presented healthy vaginal flora. In these clinical samples it was possible to isolate 16 
strains. Detailed observation of these isolates characteristics such as BV situation, 
requirements of growth conditions, morphotypes, identity and characteristics of isolated 
strains are summarized in table 2.2 and 2.3.  
2.4.2.1. Sequencing results 
 Table 2.4 shows the results of strains identification by 16S rRNA gene 
sequencing. The sequencing results were analyzed using bioinformatics methodology, 
such as the use of the BLAST database (as described in Materials and Methods) and are 
presented in Supplements section - S.1. The microorganism’s identification was 
obtained by comparing the maximum percent identity and the percent query coverage 
obtained when comparing the isolate sequence with sequences contained in the 
database. The maximum percent identity reveals the highest percentage of identical 
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bases found within the match, while the maximum score relates to the sequence 
similarity percentage that corresponds to the consultation. The query coverage, 
however, shows the percentage of the query sequence that matches the subject sequence 
(GenBank Overview, 2012: available http://www.ncbi.nlm.nih.gov/genbank/).  
 It was not possible to identify the species for 4 microorganisms isolated, 
Escherichia spp., Gemella spp., Klebsiella spp. and Streptococcus spp. as BLAST 
results only allowed to classify these strains to genus level. For instance, in the case of 
the genus Streptococcus spp., the percent query coverage and the maximum percent 
identity was the same, 100% and 99% respectively, for 3 microorganisms 
(Streptococcus salivarius, Streptococcus thermophilus and Streptococcus vestibularis 
strains). Similar results were obtained in the mentioned strains. In the future, work 
should be carried out in order to sequence other genes to identify these microorganisms 
to species level.  
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Table 2.2. Microorganisms isolated from 4 clinical vaginal swabs from women with BV (UM027, UM034, UM035 and UM054). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Features of microorganisms isolated 
  
  
     Bioquimic tests 
Vaginal isolates 
(Results of Sequencing) 
 
Bacterial 
Vaginosis 
Nutritional requirements 
of growth 
Morphotype of 
colony 
Gram staining Catalase 
test 
Oxidase 
test 
 
Bacillus firmus UM034 
 
+ 
 
CBA without supplement; 
facultative anaerobic 
 
 
 
 
 
 
 
 
Positive bacilli 
 
+ 
 
- 
Enterococcus faecalis UM035 + CBA without supplement 
media;   facultative 
anaerobic 
 
 
 
 
 
 
 
Positive cocci - - 
Gardnerella vaginalis  UM035 + CBA without supplement 
media;   facultative 
anaerobic 
 
 
 
 
 
 
 
Positive short rods 
 
- - 
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Table 2.2. (Continued). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Features of microorganisms isolated 
      Bioquimic tests 
Vaginal Isolates 
(Results of Sequencing) 
 
Bacterial 
Vaginosis 
Nutritional 
Requirements of growth 
 
Morphotype of 
colony 
Gram staining Catalase 
test 
Oxidase 
test 
 
Gemella spp. UM034 
 
+ 
 
CBA without supplement 
media;   facultative  
anaerobic 
 
 
 
 
 
Positive cocci 
 
- 
 
- 
Klebsiella  spp. UM034 + MRS media;   facultative 
anaerobic 
 
 
 
 
 
 
Negative rods 
shaped 
- - 
Mobiluncus curtisii UM027 + CBA without supplement 
media;   facultative 
anaerobic 
 
 
 
 
 
Positive curved 
rods 
- - 
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Table 2.2. (Continued). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Features of microorganisms isolated 
      Bioquimic tests 
Vaginal Isolates 
(Results of Sequencing) 
 
Bacterial 
Vaginosis 
Nutritional 
Requirements of growth 
 
Morphotype of 
colony 
Gram staining Catalase 
test 
Oxidase 
test 
Mycoplasma hominis UM054 + CBA without supplement 
media;   facultative 
anaerobic 
 Positive short rods - - 
 
Propionibacterium acnes UM034 
 
+ 
 
CBA without supplement 
media;   facultative 
anaerobic 
  
Positive rods- 
shaped 
 
+ 
 
- 
Streptococcus agalactiae UM035 + CBA without supplement 
media;   facultative 
anaerobic 
 
 
 
Positive cocci - - 
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Table 2.3. Microorganisms isolated from 4 clinical vaginal swabs from women without BV (UM016, UM022, UM031 and UM042).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Features of microorganisms isolated 
                                 Bioquimic tests 
Vaginal Isolates 
(Results of Sequencing) 
Bacterial 
Vaginosis 
Nutritional 
Requirements of growth 
Morphotype of 
colony 
Gram staining Catalase 
test 
Oxidase 
test 
Alloscardovia omnicolens UM031 - CBA without supplement 
media; facultative anaerobic  
 Positive  short 
irregularly shaped 
rods 
- - 
 
Bifidobacterium breve UM031 
 
- 
 
PURPLE media; anaerobic 
  
Positive  rod-
shaped branches 
 
- 
 
- 
Escherichia spp. UM022 - MRS media;   facultative 
anaerobic 
 
 
 
Negative rods-
shaped 
- - 
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Table 2.3. (Continued). 
  
  Features of microorganisms isolated 
      Bioquimic tests 
Vaginal Isolates 
(Results of Sequencing) 
 
Bacterial 
Vaginosis 
Nutritional 
Requirements of growth 
 
Morphotype of 
colony 
Gram staining Catalase 
test 
Oxidase 
test 
Gardnerella vaginalis UM016 - CBA with supplement 
media;   facultative 
anaerobic 
 
 Positive short rods - - 
 
Lactobacillus gasseri UM022 
 
- 
 
CBA without supplement 
media;   facultative 
anaerobic 
 
 
Positive large rods- 
shaped 
 
- 
 
+ 
Staphylococcus epidermidis UM042 - CBA without supplement 
media;   facultative 
anaerobic 
 
 
 
 
 Positive cocci + - 
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Table 2.3. (Continued). 
  Features of microorganisms isolated 
      Bioquimic tests 
Vaginal Isolates 
(Results of Sequencing) 
 
Bacterial 
Vaginosis 
Nutritional 
Requirements of growth 
 
Morphotype of 
colony 
Gram staining Catalase 
test 
Oxidase 
test 
 
Streptococcus spp. UM031 
 
- 
 
CBA without supplement 
media;   facultative 
anaerobic 
 
 
 
  
Positive spherical 
 
- 
 
- 
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Table 2.4. Results of sequencing of microorganisms isolated of vaginal clinical samples using BLAST. 
 
2.4.3. Associations between vaginal bacterial communities in women with and 
without BV 
 The isolates of vaginal cultures obtained were very distinct despite all the isolation 
process was made in the same conditions (as described in 2.3.3.2. of Materials and 
Methods) except for the medium used, because each isolate needed a specific growth 
media (Table 2.2 and 2.3). Using this methodology, 15 different species related to BV 
conditions or related with vaginal tract were identified, B. breve, E. faecalis, Escherichia 
spp., G. vaginalis, Gemella spp., Klebsiella spp., L. gasseri, M. curtisii, M. hominis, P. 
acnes, S. agalactiae, S. epidermidis, Streptococcus spp., as described previously in 
literature (Verhelst et al., 2005) except for 2 strains, A. omnicolens and B. firmus that 
were not previously identified in vaginal samples. 
 BLAST Results 
Samples Microorganisms identified 
by sequencing 
Base pairs 
amplified 
Percent Query 
Coverage 
Maximum Percent 
Identity 
UM016 Gardnerella vaginalis 612 100% 99% 
UM054 Mycoplasma hominis 313 100% 99% 
UM022 Escherichia spp. 578 100% 99% 
Lactobacillus gasseri 793 99% 99% 
UM027 Mobiluncus curtisii 754 98% 99% 
UM031 Alloscardovia omnicolens 623 100% 99% 
Bifidobacterium breve 753 98% 99% 
Streptococcus spp. 754 100% 99% 
UM034 Bacillus firmus 744 100% 98% 
Gemella spp. 745 99% 99% 
Klebsiella  spp. 734 100% 99% 
Propionibacterium acnes 745 99% 99% 
UM035 Enterococcus faecalis 759 100% 99% 
Gardnerella vaginalis 458 99% 98% 
Streptococcus agalactiae 329 98% 99% 
UM042 Staphylococcus epidermidis 206 98% 99% 
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2.4.3.1. Bacteria isolated from BV- diagnosed vaginal clinical samples 
Gardnerella vaginalis  
 The family Bifidobacteriaceae consists of only two genera, named 
Bifidobacterium and Gardnerella (Rosenstein et al., 1996). Typically Bifidobacteriaceae 
family members are considered non-pathogenic microorganisms. However the bacterium 
G. vaginalis has been recognized as the main opportunistic pathogen in BV (Forsum et 
al., 2005) as described previously in chapter 1. This microorganism was isolated of one 
sample with BV (UM035) and another G. vaginalis from one healthy vaginal sample 
(UM016). Both of them are Gram-positive, oxidase and catalase-negative bacteria. 
 
Enterococcus faecalis 
 One of the bacterium which is often isolated from vaginal samples is E. faecalis 
formerly classified as part of the group D Streptococcus system, is Gram-positive cocci 
and belongs to the family Enterobactereaceae. This microorganism was isolated from one 
clinical vaginal swab during this study, from a sample with BV, UM035. Previous studies 
revealed that E. faecalis was found in patients with signs of BV in 52.78% of cases (Jahić 
et al., 2006). The same study showed that pH change of vaginal environment was 
associated with an increase prevalence of E. faecalis, in BV cases but BV diagnosis is not 
predictable of the presence of E. faecalis in vaginal discharge.  
 
Gemella spp.  
 Gemella is a genus of Gram-positive cocci bacteria that thrive best at high partial 
pressure of carbon dioxide (CO2). The specie of the microorganism of this genus 
recovered in this study was not clearly identified. However, the possible identifications 
obtained from the sequence were G. haemolysans, G. sanquinis and G. morbillorum, with 
G. haemolysans yielding a superior maximum percent identity than of the other 2 species 
which suggests that this strain is possibly G. haemolysans. On the other hand G. 
haemolysans strains have not previously been described as a species associated with BV. 
Previously G. morbillorium has been isolated from vaginal samples and is considered 
BV-related organism (Verhelst et al., 2005).  G. haemolysans  are  residents  of the 
mucous membranes of humans  and  of certain warm-blooded  animals  and  are  
recognized  opportunistic pathogens (Collins et al., 1999). They can occur as individual 
cells, short chains, or irregular clusters, as in the case of G. morbillorum. The members of 
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this specie can grow at a wide range of temperatures with optimum growth occurring 
between 35 - 37°C. G. haemolysans is facultative anaerobic and negative for catalase and 
oxidase tests (Ruoff, 2007).  
 
Klebsiella spp. 
 In our study we isolated one strain of Klebsiella spp. from a sample of woman 
which had been diagnosed with BV (UM034). Studies have revealed that these strains are 
a successful opportunistic pathogen associated with various ailments such as urinary tract 
infections, septicaemia, respiratory tract infections and diarrhea. The specie of this 
microorganism was not clearly identified due to the similarity detected in sequence 
between the sequences obtained for Klebsiella pneumoniae and Enterobacter aerogenes 
(Supplements section S.1 – Klebsiella spp.). Klebsiella spp. belongs to the family 
Enterobactereaceae and this is described as Gram-negative rod shaped bacterium, non-
motile, encapsulated, lactose fermenting and facultative anaerobic found in the normal 
flora of the mouth, skin, and intestines (Carey and Klebanoff, 2001). Previous study 
reported that microorganisms belonging to the family Enterobactereaceae, including 
Klebsiella spp., were present in about 38% of samples from vaginal tract. However, these 
results may reflect a possible contamination of the vaginal tract by microorganisms 
normally associated with intestinal tract. Colonization with Enterobacteriaceae strains 
may also be a predisposing factor for urinary tract infection in women (Ovalle and 
Levanci, 2001). Although this microorganism has been isolated from vaginal tract 
previously, no study has been reported regarding its role and its influence on the vaginal 
tract. 
 
Mobilluncus curtisii 
 This microorganism belongs to the family Actinomycetaceae and was isolated 
from a sample of a woman with BV (UM027). After isolation and identification of M. 
curtisii UM027 the strain was stored at -80ºC with glycerol, however when further 
experiments to further characterize this strain were attempted, we were not able to recover 
it from storage, perhaps due to its fastidious characteristics. Some others vaginal samples 
also had Mobiluncus spp. (as seen in the initial Gram staining), and their presence and 
clue cells in vaginal smears has been clinically correlated with BV (Sweet, 2000) but we 
did not succeed at isolating it. Gram stains of vaginal flora from women with BV, present 
a wide spectrum of abnormalities in the vaginal ecosystem. Gram-positive and curved 
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rods, felt to represent primarily Mobiluncus spp., may be seen in some but not all women 
with BV as described in some studies (Nugent et al., 1991). One study performed by 
Sweet (2000) described that some women where Mobiluncus spp. and clue cells were 
detected appeared have a higher risk of post-abortion pelvic inflammatory disease than 
women without presence of these microorganisms. However, whether this organism is 
really pathogenic or simply indicator for disorders of vaginal flora, remains unclear 
(Meltzer et al., 2008). 
 
Mycoplasma hominis 
 M. hominis belongs to the family Mycoplasmataceae and have only been found in 
large numbers in the late stages of full-blown BV (Rosenstein et al., 1996). This 
microorganism was isolated from a sample with BV, UM054 and is a Gram-positive short 
rods bacterium. The presence of M. hominis may indicate additional risk factors for 
complications when found in women with BV. M. hominis infection was associated with 
a fishy smelling vaginal discharge, vaginal pH above 4.7, clue cells, and a positive amine 
test. Women infected with M. hominis typically had more sexually risky behavior and a 
greater likelihood of previous induced abortion or sexually transmitted disease than 
uninfected women (Mårdh et al., 1997).  
 
Propionibacterium acnes 
 One other bacterium isolated was P. acnes belonging to the family 
Propionibacteriaceae that was isolated from a sample of a woman with BV (UM034). 
This strain is relatively slow growing, largely commensal (part of the skin microflora 
present on most healthy adult human skin) (Brüggemann et al., 2004), typically 
aerotolerant anaerobic Gram-positive rod bacterium. P. acnes are found briefly on the 
skin of neonates and it may also be found throughout the gastrointestinal tract in humans, 
and true colonization is thought to begin during the 1 - 3 years prior to sexual maturity.  
P. acnes bacterium is also suspected to be subtly involved in post-operative infections, 
prostheses failure, and more recently, in inflammation of lumbar nerve roots leading to 
sciatica (Bhatia et al. 2004). Strains such as Peptostreptococcus anaerobius, P. acnes and 
E.coli have been isolated significantly more frequently from vagina of women infected 
with Chlamydia and these findings confirm importance of indole-producing bacterial 
strains in cervicitis caused by C. trachomatis (Romanik et al., 2007). 
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Streptococcus agalactiae 
 S. agalactiae is a β-hemolytic bacterium (grown in CBA without supplement) and 
belongs to the streptococcus group B and to the family Streptococcaceae. This bacterium 
is facultative, fastidious, Gram-positive cocci and can be found as part of normal vaginal, 
intestinal, and oral flora. The virulence of the organism depends largely on the 
polysaccharide capsule (Cribby et al., 2008). This microorganism may cause various 
infections in adults, but the main clinical interest in these bacteria relates to their ability to 
cause serious neonatal illness, especially meningitis and sepsis.  While  neonates  born  by 
caesarian  have presented  with  S. agalactiae infection,  indicating  ascending  
transmission  of  the microorganism  from  the  vagina  of  their  mothers it is considered 
of extreme importance in births (Regan  et al., 1981). S. agalactiae was isolated from a 
woman that was diagnosed BV (UM035). It is well known that S.  agalactiae colonizes 
the  female genital tract  but  it is unclear  if  this  bacterium can  cause true  infection of  
the  vagina.  
 
2.4.3.2. Bacteria isolated from healthy vaginal clinical samples 
Bifidobacteriaceae spp. 
Gardnerella vaginalis 
These bacteria have been described throughout this thesis as a major species 
present in BV, but that can also be isolated from women without any signs or symptoms 
of infection. Thus, it was not surprising that we isolated one G. vaginalis strain from a 
healthy woman sample (UM016). 
 
Bifidobacterium breve 
This bacterium also belongs to the family Bifidobacteriaceae as G. vaginalis, is a 
Gram-positive rod-shaped branched bacterium and oxidase and catalase-negative. B. 
breve strain was isolated in this study from healthy woman (UM031). Biﬁdobacterium 
spp. was previously found in 12% of healthy controls, in 58% of those with intermediate 
microﬂora and in 94% of patients with BV (Hyman et al., 2005). Bifidobacterium spp. 
has been described as being involved in the gradual conversion from normal to BV 
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microflora, which in turn, may implicate a rectal-vaginal pathway in the etiology of BV 
(Swidsinski et al., 2010).  
 
Escherichia spp. 
We also isolate a strain from the genus Escherichia from a healthy woman, UM022, 
but we did not identify the species of this microorganism as previously described. The 
options obtained in the BLAST analysis reported 4 strains belonging to the family 
Enterobacteriaceae, Escherichia fergusonii, Shigella flexneri, Shigella dysenteriae and E. 
coli. The genus Shigella is divided into four groups (or species), S. boydii, S. dysenteriae, 
S. flexneri and S. sonnei. Closely interrelated among them and to E. coli, which in reality 
belongs to the extremely diverse species E. coli (Lan and Reeves, 2002). E. coli strains 
are normally isolated from vaginal samples, but E. fergusonii has never been isolated 
from a vaginal sample. E. fergusonii has been associated with a wide variety of intestinal 
and extra intestinal infections (Mahapatra et al., 2005). A recent study, demonstrated that 
E. fergusonii strains have a great potential to cause human disease (Oh et al., 2012) and 
Shigella spp. members are widely known to cause human disease (Parsot, 2005).  
 
Lactobacillus gasseri 
In our study we isolated one L. gasseri strain belonging to the family 
Lactobacillaceae, from a healthy woman (UM022) these are a Gram-positive large rods-
shaped, catalase-negative and oxidase-positive. In one study reported that L. gasseri, L. 
iners, and L. jensenii were cultured from 85%, 68% and 43% of healthy women; and 
28%, 89% and 44% of BV women, respectively. The quantities of first 2 Lactobacillus 
species, had a significant difference between healthy women and women with BV as such 
the presence and quantity of Lactobacillus has an important guiding role in bacteria 
diagnostic (Dong-hui et al., 2009).   
 
Staphylococcus epidermidis 
S. epidermidis belongs to the family Staphylococcaceae and is a well-
characterized, non-fastidious, anaerobic Gram-positive cocci commonly isolated in the 
clinical microbiology laboratory (Rowlinson et al., 2006). Although coagulase-negative 
staphylococci, including S. epidermidis, are often considered a contaminant in the clinical 
laboratory, an increasing number of reports describe their pathogenesis, in particular in 
infections of prosthetic devices and their involvement in nosocomial infections (Huebner 
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and Goldmann, 1999). This isolate was unique because it grew only under strictly 
anaerobic conditions. In this study, the strain of S. epidermidis isolated came from a 
woman without BV (UM042) and it is possible that this isolate is the result of 
contamination during the collection of the vaginal sample. 
 
Streptococcus spp. 
We was also isolated Streptococcus spp. from healthy vaginal women (UM031), it 
is a Gram-positive spherical bacterium that we were not able to identify the species level 
through sequencing as it is very difficult to differentiate certain strains of Streptococcus 
spp. like S. salivarius, S. thermophilus and S. vestibularis. We obtained the same percent 
query coverage and maximum percent identity between the 3 potential candidates 
(Supplements section - S.1). Streptococci are divided into 6 phylogenetic groups: S. 
anginosus, S. bovis, S. mitis, S. mutans, S. pyogenic, and S. salivarius, with the group of 
S. salivarius consisting of only 3 distinct species, S. salivarius and S. vestibularis, 
members of the human normal microflora orally while the third, S. thermophilus, is found 
in bovine milk, all closely related (Pombert et al., 2009). Although,  S. agalactiae, S. 
anginosus, S. gallolyticus, S. mitis and S. salivarius have been previously isolated from 
the sample of vaginal exudate (Verhelst et al., 2005). S. salivarius was found to account 
for 2% of total microorganisms in healthy vaginal flora and its presence in BV samples 
has been considered not to be significant for the pathology as it is present in lower 
numbers (Rabe et al., 1988).  
 
2.4.3.3. New strains isolated in BV- diagnosed and healthy vaginal samples 
 There have been many recent additions to our knowledge regarding the human 
vaginal microbiota. Several methods, such as PCR and sequencing, have been applied to 
the study of the human vaginal microbial ecosystem, adding substantial data on bacterial 
diversity in this niche in order to understand of BV-related bacteria and their role in BV 
pathogenesis. However, as described before, the etiology and microbial ecology of BV 
remain poorly understood. Our study revealed new strains isolated from BV- diagnosed 
and healthy vaginal samples which will be described below. This data will contribute for 
improving the knowledge of human vaginal microbiota and which is critical for 
optimizing reproductive health. 
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Strain isolated from BV- diagnosed sample 
Bacillus firmus  
 One other microorganism that was isolated from BV- diagnosed women, UM034, 
was B. firmus belonging to the family Bacillaceae. It is normally isolated from soil 
samples and is described as an extracellular amylase producing strain (Singh et al., 2012). 
It is Gram-positive and aerobic bacterium, long, spore-forming rods with a diameter of < 
0.9 µm, catalase-positive and usually motile and has an optimal growth temperature of 
30ºC. This bacterium is normally used in studies related with adsorption of heavy metal 
on the polysaccharide produced by this bacterium (Salehizadeh and Shojaosadati, 2003). 
Little is known about this bacterium and no reports exist regarding its relationship with 
vaginal ecosystem. 
 
Strain isolated from healthy vaginal sample 
Alloscardovia omnicolens 
 Upon its first description (Stackebrandt et al., 1997) the family Bifidobacteriaceae 
consisted of only two genera, namely Bifidobacterium and Gardnerella, as described 
previously. Although the members of this family are considered as essentially non-
pathogenic, a number of exceptions have been reported. A. omnicolens is a member of the 
family Biﬁdobacteriaceae and is Gram-positive, catalase and oxidase-negative, non-
motile, non-spore-forming and short irregularly shaped rods. Optimal growth occurs 
under anaerobic conditions after 24 h at 37ºC, but slow aerobic growth (72 h), producing 
pinpoint-sized colonies. In this study, this microorganism was isolated in CBA without 
supplement and also produced pinpoint-sized colonies (Huys et al., 2007). This strain was 
previously isolated from various human clinical samples, but no data is currently 
available on its potential pathogenic relevance or virulence factors (Huys et al., 2007). 
This microorganism was isolated from healthy woman, UM031. No study has yet related 
the association of this microorganism with BV. 
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3.1. Introduction 
As has been described throughout this thesis, the microbial species present in the 
reproductive tract have a very important role in maintaining health and preventing 
infections. Several studies have shown that many species commonly associated with BV 
are present in thick biofilms, while dominant species in the vagina such as lactobacilli 
may be finely distributed by epithelium (Heinemann and Reid, 2005; Oakley et al., 2008).   
The vaginal tract colonization by bacteria, whether pathogens or commensals, is 
the result of adhesion of these bacteria to the vaginal mucosa and most strains possess 
adhesins encoded in their genome that allow it to colonize the vaginal mucosa. Besides 
this adhesion ability, bacteria are also capable of forming microcolonies in specific zones 
of the vagina, altering their surrounding environment and allowing their survival. This 
manipulation of the microenvironment allows microorganisms in biofilms to survive in 
the harshest environments (Costerton et al., 1999). Thus, through biofilm formation the 
survival of pathogenic bacteria becomes easier, possibly contributing to the establishment 
of BV in vaginal epithelium (Cribby et al., 2008). 
Biofilms of G. vaginalis in individuals with BV were first identified, by Scanning 
electron microscope (SEM), as a dense tissue strongly adherent to the vaginal epithelium 
comprised of bacterial cells conditioned in a matrix (Scott et al., 1989). Later 
investigations showed that G. vaginalis formed a dense biofilm in at least half of the 
epithelium in 90% of biopsies from women with BV and in only 10% of healthy women 
(Swidsinki et al., 2007). The presence of the bacterial cells in biofilm allows the bacteria 
to reach higher concentrations than in vaginal fluid and boosts their resistance both to the 
host immune system and antimicrobials agents (Srinivasan and Fredericks, 2008). In fact, 
the antibiotics can hardly reach the bacteria residing within the film in an inactive state, 
leading to a reduction in antimicrobial effectiveness (Hoiby et al., 2010).  
Typically, many women with BV initially respond to therapy (Bradshaw et al., 
2006) with metronidazole and clindamycin, the most prescribed antibiotics throughout the 
world. However, there are now recent studies that demonstrate the increasing incidence of 
resistance associated with conventional therapy using antibiotics such as metronidazole 
and clindamycin for species that have been associated with BV (Austin et al., 2005; 
Bradshaw et al., 2006). Due to the associated high rate of resistance to antibiotic therapy 
and the lack of selectivity, new therapeutic approaches have emerged, such as the use of 
probiotics. It is necessary to understand whether the loss of protective Lactobacillus spp. 
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precedes the growth of anaerobic vaginal microorganisms or otherwise if this loss of 
protective agents is secondary to massive rupture of the vaginal ecosystem. Therapy 
should include the replacement of these microorganisms and a strategy for reducing 
recurrent cases (Sobel, 2005). Moreover, in recent years, therapies with probiotics 
Lactobacillus spp. have attracted the attention of the scientific community. Some studies 
show the interest of women and adherence to these new approaches complementary 
therapy and the positive effect of its implementation (Mastromarino et al., 2009). 
3.2. Objectives 
The main objective of the work described in this chapter, was the phenotypic 
characterization of isolates from clinical vaginal samples in Portuguese women with or 
without BV. The characterization of these microorganisms is necessary to better 
understand the pathogenicity of BV condition. For this, we used in vitro assays to 
compare biofilm-forming capacity of single-species populations from BV-associated 
anaerobes and microorganisms isolated from healthy women. We used a method to 
analyze bacterial adherence to 96-well plates and compared biofilm-producing capacities 
for each isolated strains chosen. We also determined the susceptibility or resistance for 
the clinical isolates in order to find the minimum inhibitory concentration (MIC) to some 
commonly used antibiotics. 
3.3. Materials and Methods 
3.3.1. Biofilm formation method 
3.3.1.1. Media and strains used for biofilm forming assays 
For the biofilm assays, 9 different growth media (Table 3.2) were prepared: Luria 
Broth (LB – composed by 10 g/L Tryptone (Liofilchem), 5 g/L yeast extract (Liofilchem) 
and 10 g/L of Sodium chloride (ProLabo); LBG [used the same composition of LB 
medium and supplemented with 0.25% (w/v) glucose (Liofilchem)]; Man, Rogosa and 
Sharpe broth (MRS, 54.3 g/L - Liofilchem), MRSG (MRS supplemented with 0.25% 
(w/v) of glucose); Tryptic Soy Broth (TSB, 30 g/L - Liofilchem), TSBG (TSB 
supplemented with 0.25% (w/v) of glucose), sBHI [BHI supplemented by 2% (w/w) 
gelatin (Oxoid), 0.5% (w/w) yeast extract (Liofilchem), 0.1% (w/w) starch 
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(FisherScientific)] , and sBHIG [supplemented with 0.25% of glucose (Liofilchem)],  and 
finally sBHI with 10% (v/v) Fetal Bovine Serum (FBS) (Sigma-Aldrich).   
 
3.3.1.2. Biofilm formation assays 
For biofilm formation assays the first step was to prepare a pre-inoculum, in 
plastic tubes of 10 mL (Frilabo) for most of the isolated strains described in chapter 2. G. 
vaginalis AMD (BV isolate) and G. vaginalis 5-1 (non-BV isolate) were used as 
reference strains. All strains were cultured in 2 ml of different media described in 
previous section. These cultures were grown at 37ºC under anaerobic conditions; using 
the Anaerogen pack system (Oxoid) for 48 h. Growth was analyzed using a 96-well plates 
(Orange Scientific) by Enzyme-Linked Immunosorbent Assay (ELISA) reader with a 600 
nm filter (Tecan Sunrise). The cultures were diluted with different media respectively an 
OD according to the OD of the different medium used. After this step, 200 µL of each 
diluted suspension were placed in 96-well plates and incubated anaerobically at 37ºC for 
48 h.  
 
Qualitative method for analysis of biofilm formation  
Initially, biofilms were formed as described above and qualitatively quantified as 
described before by Patterson et al., (2010). Briefly, after cultures growth for 48 h, spent 
media were removed, half of 96-wells plates were washed with 200 µL 1x Phosphate 
Buffered Saline (PBS) [composed by 16 g/L of NaCl; 0.4 g/L of potassium chloride 
(KCl); 1.62 g/L of disodium phosphate (Na2HP.2H2O) and 0.4 of potassium di-hydrogen 
phosphate (KH2PO4)] to remove non-adherent bacteria, and the plates were air-dried for ± 
1 h. For qualitative assessment of biofilm formation, adherent bacteria were stained with 
200 µL 0.25% (w/v) safranin for 1 min. Following this, wells were washed gently to 
remove the safranin and the plates were air-dried. The formation of a thin or thick biofilm 
(qualitative classification) was determined by measuring the amount of safranin stained 
biofilm (by visual observation), which then had a symbol assigned to each strain: for 
strains not forming biofilm the symbol (-) was assigned, strains forming medium or 
strong biofilm (+-), and strong biofilm formation (++) in all assays.  
 
Determination of the intrinsic ability of biofilm formation 
To determine of the intrinsic capacity of biofilm formation of BV associated 
microorganisms independent of their growth rate we used the method described by 
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Harwich et al., (2010). This is important because a microorganism can have a greater 
intrinsic ability to form biofilm but form less biofilm because they might have a slower 
growth rate, for example. We selected 3 media in which each of the strains formed more 
biofilm, as determined by the qualitative analysis the pre-inoculum and biofilm forming 
assays were performed as described in the previous section, with the exception of the 
media used for each strain. After 48 h of growth, planktonic bacteria were removed from 
the wells and transferred to sterile eppendorfs. Part of 96-well plates were washed with 
200 µL 1x PBS to removed non-adherent bacteria and the plates were air-dried for ± 1 h. 
For quantitative assessment of biofilm formation, were added 200 µL of the different 
growth media to the adherent bacteria. Afterwards, wells were scraped with a pipette tip 
in order to remove the biofilm attached to the well. After this step, the biofilms formed by 
each strain (with and without PBS washing) were placed in separate sterile eppendorfs. 
The OD was measured using as a blank the different media used in each case. The 
percentage growth as a biofilm was calculated as OD600 nm biofilm/ (OD600 nm biofilm + 
OD600 nm planktonic). The data analysis was based on at least 3 independent experiments. 
 
3.3.1.3. Statistical analysis 
All the assays were compared using independent-samples T-test, using Statistical 
Package for Social Sciences (SPSS, version 18.0). All tests were performed with a 
confidence level of 95% and differences were considered significant at P < 0.05. 
 
3.3.2. Antibiotic susceptibility determination 
To identify the MIC range of each strain we used the method described by 
Harwich et al., (2010). Pre-inocula were prepared for each isolate including reference 
strains G. vaginalis AMD and G. vaginalis 5-1 (Table 3.2) in sBHI [BHI supplemented 
with 1% (w/w) of yeast extract, 2% (w/w) of gelatin, 0.1% (w/w) of starch], and 
incubated in anaerobic conditions with Anaerogen pack for ± 24 h at 37ºC. After ± 24 h 
growth the plates were measured in ELISA reader with a 600 nm filter, to confirm the 
strains growth. 5 antibiotics were diluted to a stock solution: Metronidazole (MD – 
Sigma), Tinidazole (TZ - Sigma), Clindamycin (CM - Sigma), Rifampicin (RF - Sigma) 
and Vancomycin (VM - Sigma). Antibiotics were serially diluted 2-fold in sBHI, using 
plastic tubes. After that, each of the 200 μL sBHI dilutions were placed in 96-well plates 
and 3 μL of the bacterial suspension of each strain were added to each well. The OD600 nm 
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was observed and 96-well plates were incubated in anaerobic conditions for 48 h at 37ºC 
with Anaerogen pack and the lowest concentrations of antibiotics that prevented visible 
bacterial growth were recorded. 
The main characteristics of these antibiotics are described in table 3.1 and figure 
3.1 presents the structure of the antibiotics used. 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Structure of the antibiotics used in the study described in this chapter: (A) metronidazole, (B) 
tinidazole, (C) clindamycin, (D) vancomycin and (E) rifampicin.  
Table 3.1. Characteristics of the antibiotics used in the study described in this chapter. 
Antibiotic Mechanism of action 
Metronidazole DNA damage 
Tinidazole DNA damage 
Clindamycin Protein synthesis inhibitor 
Vancomycin Cells wall synthesis 
Rifampicin RNA synthesis inhibitor 
 
A 
B C 
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3.4. Results and discussion 
3.4.1. Analysis of biofilm formation 
Biofilms are strongly associated with human infections and up to 65% of 
infections treated by physicians in the developed world have been attributed to biofilms 
(Costerton et al., 2003). 
The reproductive tract, as well as most of the cavities of the human body, is not a 
sterile environment, but a habitat for numerous species of microorganisms. Some of these 
microorganisms are commensal (beneficial to health), such as Lactobacillus spp., but 
other, harmless in normal situations, can lead to the onset of diseases (opportunistic 
pathogen) in certain conditions like has been refereed about G. vaginalis. Nowadays, little 
is known about how the different groups of bacteria involved in BV interact with the 
vaginal epithelial surface (Swidsinski et al., 2005). 
As mentioned in chapter 1, the biofilm-related diseases can be multi-species or 
single-species. Curiously, the biofilm formed from a single-species in vitro and those 
produced in nature by various consortia species have similar structural characteristics 
(Davey and O´Toole, 2000). In most biofilms it is possible to observe heterogeneity, in 
which patches of cell aggregates, not monolayers are interspersed throughout a matrix of 
exopolysaccharide (described in chapter 1) that varies in density, creating open areas, 
which allow the passage of the necessary nutrients for the survival of these species 
(Davey and O´Toole, 2000). This is due to diffusion limitations, transmitted from the 
biofilm, resulting in local variations of nutrients, pH, and availability of oxygen and 
concentrations of bacterial metabolites. In addition to these complications, the study of 
biofilms is characterized by intrinsic limitations with regard to in vitro models used in the 
assays of biofilm formation. Despite the limitations associated with the study of biofilms, 
a comprehensive comparative analysis of all data can possibly enable a breakthrough in 
the investigation of these structures (Jefferson, 2004). 
It has been described that strongly biofilm formation depends on environmental 
conditions, namely the growth media used. Many species have shown similar 
developmental steps in biofilm formation, which includes (as described in chapter 1): 
initial attachment to a surface, followed by the formation of microcolonies, and finally 
maturation of microcolonies into an EPS-encased mature biofilm. These steps are 
described as basic for single-species biofilm formation. It is thought that the process starts 
when environmental factors trigger the transition in bacteria from the planktonic growth 
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to a "living" surface. Biofilms can be formed on vast array of biotic and abiotic surfaces 
(Davey and O´Toole, 2000). In order to determine optimal conditions for in vitro biofilm 
formation, G. vaginalis and others microorganisms isolated in this study were cultured 
anaerobically in abiotic surface, 96-well plates (a non-nutritive surface, polystyrene 
plastic) with LB, MRS, TSB and sBHI media. Because glucose has been described to 
increase biofilm formation in other bacterial species (Patterson et al., 2007) these 
microorganisms were also cultured in the presence of 0.25% (w/v) of glucose (LBG, 
MRSG, TSBG and sBHIG). Furthermore sBHI media was supplemented with 10% (v/v) 
of FBS, the most widely used serum-supplement due to the very low level of antibodies 
present and because it contains more growth factors, allowing for versatility in many 
different cell culture applications. By adding these supplements to the media, bacteria 
(including planktonic bacteria) have access to different types of nutrients, and it may 
allow bacteria to adapt to different conditions and to adjust their metabolic processes to 
maximize the use of substrates available to protect themselves from harmful conditions 
and favoring biofilm production (Jefferson, 2004).  
The use of these several types of growth media allowed us to analyze the behavior 
of the clinical isolates in relation to biofilm formation (Table 3.2). Thus, it was possible to 
determine that a suitable growth media is required to initiate the formation of biofilm. 
Initially, the biofilm formation ability was screened, qualitatively, using all 9 growth 
media. Table 3.2 presents the qualitatively results of biofilm formed for each isolated 
bacteria. As expected, it can be seen that different strains have different biofilm-forming 
capability depending on the medium used. Interestingly, it is clear that certain 
microorganisms have little or no ability to form biofilm in some media such as the G. 
vaginalis UM035 and S. agalactiae UM035 in LB, LBG, MRS and MRSG media; G. 
vaginalis UM016 in MRS and MRSG media; P. acnes UM034 in MRS, MRSG, TSB, 
TSBG media and L. gasseri UM022 in media like LB, sBHIG and sBHI supplemented 
with FBS. Growth and biofilm formation for all G. vaginalis were greatest in sBHI, 
sBHIG whereas when sBHI media was supplemented with FBS this biofilm was slightly 
less dense. This medium, sBHI, was used because it is a highly nutritious general-purpose 
growth medium for culturing fastidious microorganisms and non-fastidious, such as 
streptococci and G. vaginalis and because it had already been used in some studies for 
characterization of biofilm formation in microorganisms associated with vaginal flora. 
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Table 3.2. Qualitative analysis of biofilm formed for each isolated bacterium in 9 different media, based on 
the Patterson et al., (2010) method.  
  Media 
Strains LB LBG MRS MRSG TSB TSBG sBHI sBHIG 
sBHI+FBS 
(10%) 
BV isolates          
G. vaginalis AMD +- +- +- +- +- +- ++ ++ ++ 
G. vaginalis UM035 - - - - +- +- ++ ++ ++ 
Gemella spp. UM034 ++ ++ ++ ++ +- +- +- ++ ++ 
E. faecalis UM035 +- ++ +- +- +- ++ ++ +- +- 
Klebsiella spp. UM034 +- +- +- +- +- +- +- +- +- 
P. acnes UM034 ++ ++ - - - - ++ +- ++ 
S. agalactiae UM035 - - - - ++ ++ +- ++ ++ 
          
non-BV isolates          
G. vaginalis 5-1 +- +- +- +- +- +- ++ ++ ++ 
G. vaginalis UM016 +- +- - - +- +- ++ ++ ++ 
B. breve UM031 +- ++ +- +- +- ++ ++ ++ +- 
L. gasseri UM022 - +- +- +- +- +- ++ - - 
S. epidermidis UM042 +- ++ +- +- +- ++ ++ +- +- 
Streptococcus spp. UM031 +- ++ ++ ++ ++ ++ ++ ++ ++ 
Legend: (-) no biofilm formed; (+-) formed medium or strong biofilm in all tests; (++) strong biofilm 
formation in all tests. 
As discussed in the previous chapters, most of the vaginal microorganisms are 
fastidious and difficult to culture. Patterson et al., (2010) previously reported that the 
main vaginal isolates had significantly different growth rates. They argued that the most 
appropriate method to determine biofilm formation ability would be to determine the 
percentage of growth in the biofilm, as compared to total growth (biofilm + planktonic) 
(Harwich et al., 2010). Following their method, we determined the intrinsic biofilm 
formation ability of each isolated strain, grown in sBHI (Figure 3.2a). The sBHI medium 
was chosen for this analysis because it was the only medium in which all isolated strains 
were able to form biofilm. 
Taking into account the analysis of figure 3.2a, it is possible to conclude that G. 
vaginalis BV-isolates tend to grow more in biofilms than those non-BV isolated and 
other anaerobes associated and not associated with BV (Figure 3.2a), as has been 
described in several studies (Patterson et al., 2010; Harwich et al., 2010).  We also 
observed that quantitative measurement of biofilm growth as percentage of total growth 
(Figure 3.2a) indicated that G. vaginalis AMD had a significantly greater biofilm-
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forming capacity in sBHI than the non-BV isolate G. vaginalis 5-1 as described in 
literature (Harwich MD et al., 2010). Through figure 3.2a, it was also found that some 
of the microorganisms isolated had a higher capacity to form biofilm, such as P. acnes, 
S. epidermidis, E. faecalis, Streptococcus spp. and B. breve. 
 
 
 
 
 
 
 
 
 
 
Figure 3.2a. Intrinsic ability of biofilm formation of each strain in sBHI. This assay was performed at 37ºC, 
during 48 h. After this time the suspension was removed, and biofilms were subjected to one wash with 1x 
PBS to analyze the strength of attachment. The percent growth was calculated as OD 600 nm biofilm/ (OD 600 
nm biofilm +OD 600 nm planktonic). Error bars represent the standard deviation of 3 independent experiments. 
Statistical differences are marked with* (P < 0.05) from biofilm formation of these strains with washing or 
no washing of the cells with PBS buffer after removed planktonic cells were analyzed using independent-
samples T-test. 
To assess the strength of the association of the biofilm onto the surface to which it 
is attached, the biofilms were washed with PBS to remove cells that are not strongly 
adhered and compared to biofilms where the growth media was completely removed, 
but without washing, from our results it is possible to see that the PBS wash did not 
result in significant differences in biofilm formation (T-test, P > 0.05) except in the case 
of S. agalactiae UM035 and L. gasseri UM022 which indicates that the biofilm formed 
by these strains are not as strong as the others strains (T-test, P < 0.05). 
The relationship between biofilm-forming capacity and association with BV was 
further investigated using the others strains isolated in this work and by quantitatively 
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analyzing the intrinsic capability of biofilm formation under the 3 best growth media, as 
determined qualitatively. We found that the BV-isolated G. vaginalis (G. vaginalis 
UM035), had similar biofilm formation tendency as G. vaginalis AMD strain and more 
than non-BV isolated strains, namely G. vaginalis 5-1 and G. vaginalis UM016. By 
observing the results from the other strains isolated in this study, it was possible to 
conclude that those isolated from women with BV have a stronger intrinsic capacity to 
grow as a biofilm than those isolated from healthy women. However, the differences 
detected were not statistically significant (T-test, P > 0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2b. Intrinsic ability of biofilm formation of each strain in different media. This assay was 
performed at 37ºC, during 48 h. After this time the suspension was removed, and biofilms were subjected to 
one wash with 1x PBS to analyze the resistance thereof. The percentage growth was calculated as OD 600 nm 
biofilm/ (OD 600 nm biofilm + OD 600 nm planktonic). Error bars represent the standard deviation of 3 
independent experiments. Statistical differences are marked with* (P < 0.05) from biofilm formation of 
these strains with washing or no washing of the cells with PBS buffer after removed planktonic cells were 
analyzed using independent-samples T-test. 
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Figure 3.2b. (Continued). 
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Figure 3.2b.  (Continued).  
In general it appears that G. vaginalis forms more biofilm when adding glucose to 
the medium or sBHI normal. It was found that with the use of a more complex substrate 
such as sBHI + 10% FBS decreases the ability to form biofilm in the 2 strains of G. 
vaginalis isolated (Figure 3.2b). The components in this type of substrate may affect 
somewhat the structure of the biofilm formation. This is an extremely complex mixture of 
many small and large biomolecules with different, physiologically balanced growth-
promoting and growth-inhibiting activities. Some of the major functions of serum are to 
provide growth factors, hormones, attachment and spreading factors, binding proteins, 
lipids, and minerals (Freshney et al., 1994). Nonetheless, one study reported that the 
serum had influence in Helicobacter pylori bacteria in relation to their adherence and 
promotes their inhibition to abiotic surfaces, due the fact that these media complicate 
studies of bacterial metabolism and may not accurately represent the in vivo environment 
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(Williams et al., 2008). So our results, demonstrate the same results wherein it is found 
that strains of G. vaginalis not adhere so well in the presence of a substrate with FBS as 
preferred substrate glucose and normal supplement sBHI, as possible to see in figure 3.2b.  
Besides the high growth tendency as biofilms of G. vaginalis, we also detected 
other organisms with similar growth trends, such as, S. epidermidis, E. faecalis, 
Streptococcus spp. and B. breve. S. epidermidis is known to possess an extracellular 
polyssaccaride adhesin, which is encode by ica operon, that represents a key virulence 
determinant in this bacterium and is required for biofilm formation (O´Gara and 
Humphreys, 2001) and E. faecalis is known to form dense biofilm (Kristich et al., 2004). 
In the case of E. faecalis, many studies reported that this bacterium has the capability to 
make surface pilli which can lead to the formation of a biofilm (Nallapareddy et al., 
2006). Relatively to P. acnes, this bacterium has also been described to form biofilm 
nevertheless nothing is known about the regulation of bioﬁlm production (Bayston et al., 
2007).  
On the other hand, the others anaerobes tested - L. gasseri, Gemella spp., 
Klebsiella spp. and S. agalactiae demonstrated lower biofilm formation capability, as 
compared to G. vaginalis, but it should be noted that L. gasseri had a higher ability to 
form biofilm than S. agalactiae and Klebsiella spp. This phenomenon can be explained 
by the fact that in the case of healthy women (as is the case of the isolated strain of 
Lactobacillus), biofilms in the vaginal tract are mainly constituted by lactobacilli, which 
have various mechanisms of adhesion that allow them to colonize effectively the vaginal 
mucosa. It is known that the adhesion of epithelial cells is accomplished through various 
receptors available in the vaginal mucosa and that L. gasseri strains bind to the vaginal 
epithelium through glicopeptidic receptors. Thus, the various epithelial receptors become 
a target for competition between bacteria in the vaginal mucosa, demonstrating the 
protective role of lactobacilli in the epithelium preventing connections of the epithelial 
receptors with other potentially pathogenic or opportunistic bacteria (Hajela et al., 2012). 
Although, it has been described that S. agalactiae is a common commensal organism, it 
may become pathogenic and endanger the life of newborns. These pathogens are 
characterized by presenting long filamentous structures, known as fimbriae or pilli, which 
are often involved in initial adhesion of bacteria to host tissues but also in bacteria-
bacteria interactions, resulting in biofilm formation. Studies report that these 
microorganisms can form biofilms and those pilli play an important role in this process 
(Konto-Ghiorghi et al., 2009). 
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Results of some investigations into the ability of G. vaginalis and other BV-
associated anaerobes, demonstrated that controversy exists as to whether G. vaginalis is 
the cause of BV or the enhancing agent BV (Patterson et al., 2010). Since G. vaginalis 
has been shown as the predominant species in biofilms in women presenting with BV, 
comparatively with others BV-associated anaerobes, it suggests the important role of 
biofilms in the pathogenesis of this condition (Patterson et al., 2010). The present study, 
only evaluated the biofilm formation ability of a single species and not several mixed 
biofilm-associated microorganisms which could reveal more information about strain 
interaction. One other limitation of this study is the restricted number of strains studied, 
as they were dependent on exudate vaginal samples received.  
3.4.2. Determination of susceptibility to antibiotics 
3.4.2.1. Characterization of treatment with antibiotics in BV 
BV treatment has been based on empiricism, mainly due to the absence of an 
identified etiological agent, as discussed thought this thesis (Josey and Schwebke, 2008). 
The magnitude BV consequences has stimulated therapeutic research efforts towards the 
development more effective therapies (Menard, 2011). However, treating BV remains 
complicated, and antibiotic resistance is postulated as one of the reasons for persistence 
and recurrence of BV. Several studies report that the capacity of antibiotics to penetrate 
the biofilm is reduced, and considering the presence of biofilms associated with BV, 
antimicrobial resistance can be seriously enhanced (Hogan and Kolter, 2002). Antibiotics 
like nitroimidazoles (such as metronidazole and tinidazole), have been commonly used in 
the treatment of BV. There determining the susceptibility to metronidazole of the isolated 
strains of G. vaginalis and others vaginal anaerobes (associated or not with BV) is of the 
upmost importance to detect any emergence of resistance as well as to identify the 
appropriate therapeutic agents for use in the treatment of invasive diseases caused by G. 
vaginalis (Polatti et al., 2012).  
At the moment there are 3 recommended therapies for BV, oral metronidazole or 
vaginal clindamycin (Verstraelen and Verhelst, 2009) and more recently tinidazole. So, 
the aim of this study was to determine the MIC of the 13 isolates obtained in this study 
against 5 antibiotics, 3 of them commonly used against BV (metronidazole (MD), 
tinidazole (TZ) and clindamycin (CM)) and also rifampicin (RF) and vancomycin (VM). 
Table 3.3 shows the  MIC’s, as determined by dilution assay in 96-well plates.  
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Table 3.3.  In vitro susceptibilities of microorganisms isolated from clinical samples to 5 antimicrobial 
agents: Metronidazole (MD), Tinidazole (TZ), Clindamycin (CM), Rifampin (RF) and Vancomycin (VM) 
using method described by Harwich et al., (2010) in 3.3.2 section of Materials and Methods. 
 
Antibiotics – MIC range (µg/mL) 
Strains MD TZ CM RF VM 
BV isolates      
G. vaginalis AMD 16 - 32 16 - 32 8 -16 0.25 – 0.5 0.25 - 0.5 
G. vaginalis  UM035 16 4 - 32 > 128 0.125 0.25 - 0.5 
      
non-BV isolates      
G. vaginalis 5-1 128 128 16 - 64 0.5 - 1 0.5 - 1 
G. vaginalis UM016 32 - 64 8 - 32 64 - 128 0.25 – 0.5 0.25 – 0.5 
      
BV isolates      
E. faecalis UM035 > 128 > 128 > 128 16 2 - 4 
Gemella spp. UM034 < 16 < 4 < 0.5 < 0.03 < 0.125 
Klebsiella  spp. UM034 > 128 > 128 > 128 64 64 - 128 
P. acnes UM034 64 - 128 > 128 0.5 - 2 0.03 - 2 0.125 
S. agalactiae UM035 > 128 > 128 > 128 1 - 2 1 - 2 
      
non-BV isolates      
B. breve UM031 16 4 - 8 > 128 0.125 - 0.25 0.125 - 0.5 
L. gasseri UM022 > 128 > 128 > 128 1 - 2 0.5 - 2 
S. epidermidis UM042 > 128 > 128 > 128 4 - 8 > 64 
Streptococcus spp. UM031 > 128 > 128 > 128 32 - 64 2 
 
Metronidazole and Tinidazole 
MD was first used in trichomoniasis and anaerobic infections but has more 
recently been used in treatment of BV with good clinical results (Löfmark et al., 2010). In 
an earlier study it has observed that the majority of strains of G. vaginalis examined were 
susceptible to MD and TZ (Kharsany et al., 1993) but a recent study demonstrated that 
recent strains of G. vaginalis isolated are more resistant (Harwich et al., 2010). Generally, 
strains with MIC ≤ 8 µg/mL are considered susceptible, whereas those having an MIC = 
16 µg/mL are considered intermediate resistant and finally with bacteria MIC ≥ 32 µg/mL 
are considered resistant to MD (Hecht et al., 2001). Having this in consideration, our MIC 
results were of some concern, since all strains in this study were intermediate or resistant 
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to MD and similar results were obtained with TZ. Several mechanisms have been 
proposed for MD resistance in anaerobic bacteria, although different mechanisms might 
be involved in different organisms, but resistance as a decrease in antibiotic absorption 
efficiency or altered reduction is a common explanation. Most Gram-positive anaerobic 
bacteria such as Bifidobacterium, Lactobacillus and Propionibacterium spp. intrinsically 
have reduced susceptibility to MD (Löfmark et al., 2010). Results similar to those 
obtained in this study have previously been reported where all strains tested demonstrated 
intermediate resistance or full resistance to MD (range for lactobacilli, including L. 
gasseri was > 256 µg/ml) (Reid et al., 2003). The strains that presented intermediate 
resistance were B. breve, G. vaginalis AMD and UM035 and Gemella spp. UM034. One 
other study using the same controls, G. vaginalis AMD and 5-1 also showed that these 
strains also presented intermediate resistance to MD (Harwich et al., 2010). Interestingly, 
the MIC for MD for a strain G. vaginalis isolated from a healthy woman, G. vaginalis 
UM016 (MICs range, 32 - 64 µg/mL) was higher than the MIC for the strain of G. 
vaginalis isolated from women with BV as G. vaginalis UM035 (MIC = 16 µg/mL).  
Results of several experiments demonstrate that the fact that the vaginal flora in 
BV is comprised of several Gram-variable bacteria, like G. vaginalis, means that 
antimicrobials specifically active against Gram-positive or Gram-negative bacteria have 
little or no action against Gram-variables microorganisms (Gilbert et al., 1997). This fact 
might explain the resistance observed in G. vaginalis strains over time. However, it is still 
possible to observe that the remaining strains also are very resistant to MD, as they 
required concentrations above 128 µg/mL.  
TZ is chemically similar to MD and has a shorter treatment course. TZ may be a 
therapeutic alternative in the treatment of BV as it requires less than half the 
recommended dose of oral MD (Schwebke and Desmond, 2011), and as such it has been 
licensed recently in the US for the treatment of BV (Bradshaw et al., 2012). Although 
studies have shown that TZ is now the antibiotic of choice in combating BV, our results 
show that most microorganisms isolated in our study, including G. vaginalis, were 
resistant, except B. breve non-BV isolate (MIC range was 4 - 8 µg/mL) and Gemella spp. 
BV-isolate (MIC range was < 4 µg/mL) that demonstrated sensibility to this antibiotic. It 
should be noted that in the case of G. vaginalis UM035, that was BV-isolate, the MIC 
was variable 4 - 32 µg/mL and all of other BV-isolates were intermediate resistant or 
resistant (MIC range with high variability, 16 - 128 µg/mL). Results suggest that L. 
gasseri UM022 a non-BV isolate was resistant in agreement with previous studies, which 
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show that MD and TZ did not affect the normal microorganisms present in vaginal flora 
like L. gasseri (Polatti, 2012). Our results did not support the hypothesis that TZ is more 
efficacious for the treatment of BV than MD (Schewebke and Desmond, 2011) because 
we obtained only 2 strains, B. breve (MIC range, 4 - 8 µg/mL) and Gemella spp. (MIC 
range, < 4 µg/mL) were shown to be susceptible and all of others isolates present 
intermediate resistance (MIC range, 4 - 32 µg/mL).  
Clindamycin 
CM is the second antibiotic of choice used to treat BV. Belonging to the class of 
lincosamides, CM exhibits its action by inhibiting bacterial protein synthesis. CM has 
larger spectrum activity against Gram-positive aerobes and anaerobes (Bradshaw et al., 
2012). In our results, only Gemella spp. (MIC range, < 0.5 µg/ mL) and P. acnes (MIC 
range, 0.5 - 2 µg/ mL), were found to be sensible to CM as previously reported (Buu-Hoi 
et al., 1982; Nishijima et al., 1996). Comparatively to others studies, bacteria are 
commonly susceptible to CM, including G. vaginalis strains and other vaginal aerobes 
and anaerobes (Backer et al., 2006). However, in the present study, this was not the case 
since they revealed intermediate resistant or resistant phenotype even in the case of G. 
vaginalis AMD and 5-1 (Patterson et al., 2010). 
CM, while useful in combating BV is known to affect lactobacilli and thus results 
in a negative effect on the normal flora, increasing the potential for microbial diseases 
(Polatti, 2012). Other studies suggest that L. crispatus, for example, is more susceptible to 
CM than strains of L. gasseri. For this reason, it is possible that treatment using CM can 
reduce the resistance or protection conferred by lactobacilli to pathogen vaginal 
colonization. Moreover it is becoming apparent from clinical studies comparing CM and 
MD, that resistance to CM seems to develop more readily than resistance to MD (Beigi et 
al., 2004).  
A study undertaken this year in Portugal, has shown that the first choice 
antimicrobial therapy is MD (58%) (Henriques et al., 2012), as has previously described 
in other countries (Schmid, 1999). It was also found that specialists in different 
geographical regions of Portugal’s prescribe different antibiotic therapies. The center 
region of Portugal, was the only region where CM prescriptions preferred to MD, and 
although Portuguese doctor’s do not regard recurrence as very common (in contrast to 
other parts of world) in the region with the highest rate of CM use perception of 
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recurrence rate was slightly elevated. Despite Portuguese doctor perceptions of low 
recurrence rates, our results indicate high levels of resistance to MD, TZ and CM from 
the isolates recovered in this study. However, since we were only able to isolate a few 
strains of each species, we can not infer to the widespread presence of resistant BV 
bacteria in Portugal. 
 Vancomycin 
VM acts by inhibiting cell wall biosynthesis in Gram-positive bacteria and is not 
active against Gram-negative bacteria (Van Wageningen et al., 1998). Since the start of 
its use, VM has shown to be very useful and for 3 decades there were no reports of 
resistance to this antibiotic. However, recently reports have emerged on the isolation of E. 
faecalis resistant to high concentrations of VM (Nicas et al., 1989) and as such we 
decided to include this antibiotic in our susceptibility tests, in order to best assess overall 
resistance patterns in our isolates. In our results, we observed that E. faecalis BV-isolate 
was susceptible to VM in this case (MIC range, 2 - 4 µg/ mL). All strains, except S. 
epidermidis and Klebsiella spp., were sensitive to low concentrations of VM (MIC range, 
0.125 - 2 µg/ mL). In the case of Klebsiella spp. it was not surprising that it was resistant 
as it is a Gram-negative organism. VM resistance among coagulase-negative 
staphylococci was first reported over 20 years (Siebert et al., 1979). Since that time, there 
have been several case reports of clinically significant coagulase-negative with decreased 
susceptibility to VM (Krcmery et al., 1996; Dunne et al., 2001). Further studies, have 
demonstrated that the incidence of these resistant organisms is very low. Possible 
explanations referred by Srinivasan et al., (2002) for this resistant phenotype include the 
use of high levels of VM in the months prior to the study, the fact that these isolates were 
all part of an outbreak, or the possibility that the researchers used a more sensitive 
technique to detect resistance VM. Unfortunately, none of these factors was addressed in 
the study.  
Results obtained for L. gasseri, B. breve were similar to those obtained in other 
investigations (Backer et al., 2006).  
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Rifampicin 
RF is a bactericidal antibiotic drug whose activity relies on the inhibition of 
protein synthesis (Calvori et al., 1965) and has been used in in vitro assays of several 
isolates related to BV for susceptibility testing (Backer et al., 2006; Harwich et al., 2010).  
Our results demonstrate that with the exception of certain species of 
microorganisms, RF was highly active against most anaerobes tested, except for E. 
faecalis that demonstrated intermediated resistance (MIC = 16 µg/mL), Klebsiella spp. 
(MIC = 64 µg/mL) and Streptococcus spp. (MIC range, 32-64 µg/mL) that were resistant. 
Bacteria can become resistant to an antibiotic because they mutate easily and frequently. 
Resistance to RF arises from mutations that alter residues of the RF binding site on RNA 
polymerase, resulting in decreased affinity for this antibiotic (Wehrli, 1983).  
Our tests showed a low MIC - value for RF (MIC range for L. gasseri: 1 - 2 
µg/mL) that was similar with other results published (Backer et al., 2006). In this case, 
there were no significant differences regarding the effect of this antibiotic in isolates of 
BV and healthy samples. This result, together with the results obtained for VM suggest 
that lower concentrations of VM and RF are sufficient to damage the lactobacilar flora 
(Backer et al., 2006), although they were very active against G. vaginalis. Thus, despite 
this, we conclude that these antibiotics can not be used in the treatment of BV, because 
contribute to damaging microorganisms which are promoters of a healthy vaginal flora.  
 
Conclusions from this study suggest that compared with previous studies, which 
are now some years old, there has been an increase in resistance to certain antibiotics 
(MD, TZ and CM) (Ayesha et al., 1993; Patterson et al., 2010). This is the first and single 
study in Portugal in which phenotypic characterization of the vaginal microbial strains 
was performed according to biofilm formation and antibiotic susceptibility. It can be said 
that strains of G. vaginalis isolated from Portuguese clinical samples appear to be more 
resistant to antibiotics commonly used in other studies, than other strains of G. vaginalis, 
elsewhere.  
Conducting studies such as this,  is important for the study of the vaginal 
microbiota, to better understand the preponderant factors that lead to BV becomes 
possible the development of new treatment regimens for BV, such as treatment with 
probiotics. 
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It is a fact that with regards to Bacterial Vaginosis (BV), there are still many 
questions regarding the elucidation of its pathogenesis. Therefore, in order to find 
answers to some of the questions related to BV, we aimed to isolate several species from 
the vaginal flora of Portuguese women and study its virulence potential in the scope of 
BV. 
Firstly, our study revealed novel strains isolated from cases of healthy or women 
with BV. This data will contribute to a better understanding of human vaginal microbiota 
which is fundamental for the optimization of reproductive health. Furthermore, besides 
the identification of bacterial species involved, their phenotypic characterization was 
considered essential in this study. Through the evaluation of the intrinsic capacity to grow 
as biofilm, we verified that Gardnerella vaginalis isolated from a case of BV showed the 
highest capacity for growth as biofilm. It was also found that some of the microorganisms 
isolated despite not having the same intrinsic capacity to form biofilm as G. vaginalis, 
also had high capacity to grow as biofilm, such as Enterococcus faecalis, Streptococcus 
spp., Bifidobacterium breve and Propionibacterium acnes. There are few studies related 
to the capacity to form biofilm of in strains isolated from vaginal flora (other than some 
Lactobacillus spp. and G. vaginalis) both in cases of healthy women or BV-diagnosed 
women.  
Although, our results do not point to clear evidence that could lead to the 
confirmation of the etiological agent of BV, we shown than many of the organisms found 
on BV do not have a high virulent potential, per se. Furthermore, the only possible 
virulence factor studied was the potential of intrinsic capacity to form biofilm of these 
strains, so further studies must be done in this context. It is also worth to note that G. 
vaginalis and most microorganisms isolated in this study, with a high capacity to form 
biofilm, also demonstrate intermediate resistance or resistance to traditional antibiotics 
(metronidazole, tinidazole and clindamycin), and this was not surprising as resistance 
cases have been reported in studies conducted in other countries.  
Follow up studies of interest that would improve some of the knowledge 
originated from this work, would be the study of mixed biofilm formation which could 
allow for the analysis of whether there is or not, a change in biofilm formation in the 
different cases of BV, and to test the hypothesis that G. vaginalis associated with others 
microorganisms can become more virulent. Clearly, isolating more different species and 
even different strains from the same species would be of interest, in order to achieve 
epidemiological significance.  
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Furthermore, characterization of the isolated strains at the level of expression of 
virulence genes (in the case of G. vaginalis - cytolysin secreted called vaginolysin, gene 
for vaginolysin, (vly) and biofilm-forming proteins (BAP) the gene identified (Bapl)) in 
each of the BV-associated microorganisms and non-BV isolates would allow for a better 
understanding of their virulence traits when in presence or absence of the other anaerobes. 
Testing of new therapeutic strategies in the isolated strains, such as the use of 
Lactobacillus spp. as part of the treatment of BV (probiotic treatment) and research for 
natural alternative treatments like using the compounds, that are naturally produced by 
Lactobacillus spp., and that could potentially be active against pathogenic bacteria 
isolated, would also be of great importance.  
Pursuing these experiments will contribute to the better understanding of BV and 
its impact in women’s health. 
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S.1 – Results of sequencing and BLAST 
Staphylococcus epidermidis UM042 (206 bp) 
CTATACATGCAGTCGAGCGAACAGACGAGGAGCTTGCTCCTCTGACGTTAGCGGCGGACGGGT
GAGTAACACGTGGATAACCTACCTATAAGACTGGGATAACTTCGGGAAACCGGAGCTAATAC
CGGATAATATATTGAACCGCATGGTTCAATAGTGAAAGACGGTTTTGCTGTCACTTATAGATG
GATC 
 
Streptococcus agalactiae UM035 (329 bp) 
CTACACATGCAGTAGAACGCTGAGGTTTGGTGTTTACACTAGACTGATGAGTTGCGAACGGGT
GAGTAACGCGTAGGTAACCTGCCTCATAGCGGGGGATAACTATTGGAAACGATAGCTAATAC
CGCATAAGAGTAATTAACACATGTTAGTTATTTAAAAGGAGCAATTGCTTCACTGTGAGATGG
ACCTGCGTTGTATTAGCTAGTTGGTGAGGTAAAGGCTCACCAAGGCGACGATACATAGCCGAC
CTGAGAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAAACTCCTACGGGAGGCAGCA
GTAG 
Accession Description Query coverage Max ident 
NR_040821.1 Streptococcus agalactiae ATCC 13813 
strain JCM 5671 16S ribosomal RNA, 
complete sequence 
98% 99% 
NR_036918.1 Streptococcus suis strain S735 16S 
ribosomal RNA, partial sequence 
98% 94% 
NR_037101.1 Streptococcus urinalis strain 2285-97 16S 
ribosomal RNA, partial sequence 
98% 94% 
 
 
Mycoplasma hominis UM054 (313 bp) 
AACAAACAGCCTACGAACGCTTTACGCCCAATAATTCCGGATAACGCTTGCGACCTATGTATT
ACCGCGGCTGCTGGCACATAGTTAGCCATCGCTTTCTGACCAGGTACCGTCAGTCTGCAATCA
TTTCC 
Accession Description Query coverage Max ident  
NR_036904.1 Staphylococcus epidermidis strain Fussel 
16S ribosomal RNA, partial sequence 
98% 99% 
NR_027519.1 Staphylococcus capitis subsp. urealyticus 
strain MAW 8436 16S ribosomal RNA, 
partial sequence 
98% 97% 
NR_024665.1 Staphylococcus caprae strain ATCC 35538 
16S ribosomal RNA, partial sequence 
98% 97% 
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Accession Description Query coverage Max ident 
NR_041881.1 Mycoplasma hominis ATCC 23114 strain 
PG21 16S ribosomal RNA, complete 
sequence 
100% 99% 
NR_025135.1 Mycoplasma phocidae strain 105 16S 
ribosomal RNA, partial sequence 
100% 96% 
NR_024984.1 Mycoplasma falconis strain H/T1 16S 
ribosomal RNA, partial sequence 
97% 97% 
 
 
Lactobacillus gasseri UM022 (793 bp) 
ATCAGCGTCAGTTGCAGACCAGAGAGCCGCCTTCGCCACTGGTGTTCTTCCATATATCTACGC
ATTCCACCGCTACACATGGAGTTCCACTCTCCTCTTCTGCACTCAAGTTCAACAGTTTCTGATG
CAATTCTCCGGTTGAGCCGAAGGCTTTCACATCAGACTTATTGAACCGCCTGCACTCGCTTTAC
GCCCAATAAATCCGGACAACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACGTAGTTAG
CCGTGACTTTCTAAGTAATTACCGTCAAATAAAGGCCAGTTACTACCTCTATCTTTCTTCACTA
CCAACAGAGCTTTACGAGCCGAAACCCTTCTTCACTCACGCGGCGTTGCTCCATCAGACTTGC
GTCCATTGCGGAAGATTCCCTACTGCTGCCTCCCGTAGGAGTTTGGGCCGTGTCTCAGTCCCAA
TGTGGCCGATCAGTCTCTCAACTCGGCTATGCATCATTGCCTTGGTAAGCCGTTACCTTACCAA
CTAGCTAATGCACCGCAGGTCCATCCAAGAGTGATAGCAGAACCATCTTTTAAACTCTAGACA
TGCGTCTAGTGTTGTTATCCGGTATTAGCATCTGTTTCCAGGTGTTATCCCAGTCTCTTGGGCA
GGTTACCCACGTGTTACTCACCCGTCCGCCGCTCGCTTGTATCTAGTTTCATCTGGTGCAAGCA
CCAAATTCATCTAGGCAAGCTCGCTCGACTTGCATGTATTAGGCACGCCGCCAGCGTTCGTCCT
GAGCCACT 
Accession Description Query coverage Max ident  
NR_041920.1 Lactobacillus gasseri ATCC 33323 16S 
ribosomal RNA, complete sequence 
99% 99% 
NR_044507.1 Lactobacillus taiwanensis strain BCRC 
17755 16S ribosomal RNA, partial sequence 
99% 99% 
NR_025273.1 Lactobacillus johnsonii strain ATCC 33200 
16S ribosomal RNA, partial sequence 
97% 99% 
 
Escherichia spp. UM022 (578 bp) of sequence 
GAGCGTCAGTCTTCGTCCAGGGGGCCGCCTTCGCCACCGGTATTCCTCCAGATCTCTACGCATT
TCACCGCTACACCTGGAATTCTACCCCCCTCTACGAGACTCAAGCTTGCCAGTATCAGATGCA
GTTCCCAGGTTGAGCCCGGGGATTTCACATCTGACTTAACAAACCGCCTGCGTGCGCTTTACG
CCCAGTAATTCCGATTAACGCTTGCACCCTCCGTATTACCGCGGCTGCTGGCACGGAGTTAGC
CGGTGCTTCTTCTGCGGGTAACGTCAATGAGCAAAGGTATTAACTTTACTCCCTTCCTCCCCGC
TGAAAGTACTTTACAACCCGAAGGCCTTCTTCATACACGCGGCATGGCTGCATCAGGCTTGCG
CCCATTGTGCAATATTCCCCACTGCTGCCTCCCGTAGGAGTCTGGACCGTGTCTCAGTTCCAGT
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GTGGCTGGTCATCCTCTCAGACCAGCTAGGGATCGTCGCCTAGGTGAGCCTTTACCCCACCTA
CTAGCTAATCCCATCTGGGCACATCCGATGGCAAGAGGCCCGAAGGT 
Accession Description Query coverage Max ident  
NR_027549.1 Escherichia fergusonii ATCC 35469 16S 
ribosomal RNA, partial sequence 
100% 99% 
NR_026331.1 Shigella flexneri strain ATCC 29903 16S 
ribosomal RNA, partial sequence 
100% 99% 
NR_026332.1 Shigella dysenteriae strain ATCC 13313 16S 
ribosomal RNA, partial sequence 
100% 99% 
 
Gardnerella vaginalis UM016 (612 bp of sequence) 
CTTCTAGCGTCAGTAACAGCCCAGAGACCTGCCTTCGCCATTGGTGTTCTTCCCGATATCTACA
CATTCCACCGTTACACCGAGAATTCCAGTCTCCCCTACTGCACTCTAGCCCGCCCGTACCCGGC
GCAAACCCACCGTTAAGCGATGGGCTTTCACACCAGACGCGACGAACCGCCTACAAGCTCTTT
ACGCCCAATAATTCCGGATAACGCTTGCGCCCTACGTATTACCGCGGCTGCTGGCACGTAGTT
AGCCGGCGCTTATTCGAAAGGTACACTCACCCAAAAGGCTTGCTCCCAATCAAAAGCGGTTTA
CAACCCGAAGGCCTTCATCCCGCACGCGGCGTCGCTGCGTCAGGGTTTCCCCCATTGCGCAAT
ATTCCCCACTGCTGCCTCCCGTAGGAGTCTGGGCCGTATCTCAGTCCCAATGTGGCCGTCCGCC
CTCTCAGGCCGGCTACCCGTCGAAGCCTAGGTGGGCCATTACCCCGCCTACAAGCTGATAGGA
CGCGACCCCATCCCATGCCACTAAACACTTTCCCAACAAGACATGCGTCAAGTTGGAGCATCC
AGCATTACCACCCGTTTCCAAGAGCT 
Accession Description Query coverage Max ident 
NR_044694.1 Gardnerella vaginalis 16S ribosomal RNA, complete 
sequence 
100% 99% 
NR_044692.1 Bifidobacterium minimum 16S ribosomal RNA, 
complete sequence 
99% 93% 
NR_029065.1 Bifidobacterium psychraerophilum strain T16 16S 
ribosomal RNA, partial sequence 
99% 93% 
 
Mobilincus curtisii UM027 (754 bp) 
CGCTCTCAGTGTCAGTAACGGCCCAGTGACCTGCCTTCGCCATCGGTGTTCCTCCTGATATCTG
CGCATTCCACCGCTACACCAGGAATTCCAGTCACCCCTACCGCACTCAAGCCCGCCCGTACCC
ACCGCAGACCAACAGTTAAGCTGCTGGCTTTCACGACAGACGCGACGAACCACCTACGAGCTC
TTTACGCCCAATAAATCCGGACAACGCTCGCGCCCTACGTATTACCGCGGCTGCTGGCACGTA
GTTAGCCGGCGCTTCTTCCCCCACTACCATCAACACAGCCAAAACTGTGCCTTTTTCGCGAGAA
AAAGGAGTTCACAACCCGAAGGCCTACACCCTCCACGCGGCGTCGCTGCATCAAACTTTCGTC
CATTGTGCAATATTCCCCACTGCTGCCTCCCGTAGGAGTCTGGGCCGTATCTCAGTCCCAGTGC
GACCGACCACCCTCTCAGGCCGGCTACCCGTCAAAGCCTTGGTAAGCCATCACCCCACCAACA
AGCTGATAGGCCGCGAGCCCACCCAATCCCAGAAAAAACCTTTCCAAACACCACCATGCGGT
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GACGCCTGAATATCCAGTATTAGCAGCCGTTTCCAGCCGTTATCCCAAAGAAAAGGACAGGTT
ACTCACGTGTTACTCGCCCGTTCGCCACTAATCCACCACAGCAAGCTGCGGCTTCATCGTTCGA
CTTGCATGTGTTAAGCACGCCGCCAGCGTTCGTCCTGAGCCAAA 
Accession Description Query coverage Max ident  
 
NR_042124.1 
 
Mobiluncus curtisii subsp. holmesii ATCC 35242 
strain : CCUG 17762 16S ribosomal RNA, partial 
sequence 
 
98% 
 
99% 
NR_042085.1 Mobiluncus curtisii subsp. curtisii ATCC 35241 strain 
CCUG 21018 16S ribosomal RNA, partial sequence 
97% 99% 
NR_042086.1 Mobiluncus mulieris strain CCUG 20071 16S 
ribosomal RNA, partial sequence 
98% 98% 
 
Alloscardovia omnicolens UM031 (623 of sequence) 
CTCAGCGTCAGTAATAGCCCAGAGACCTGCCTTCGCCATTGGTGTTCTTCCCGATATCTACACA
TTCCACCGTTACACCGAGAATTCCAGTCTCCCCTACTACACTCTAGCCTGCCCGTACCCAGCGC
CAATCCACCGTTAAGCGATGGACTTTCACACCAGACGCGACAAACCGCCTACGAGCTCTTTAC
GCCCAATAATTCCGGACAACGCTTGCACCCTACGTATTACCGCGGCTGCTGGCACGTAGTTAG
CCGGTGCTTATTCAAAAGGTACACTCACTCACGCTTGCTCCCCAATAAAAGCGGTTTACAACC
CGAAGGCCGTCATCCCGCACGCGGCGTCGCTGCATCAGGGTTCCCCCCATTGTGCAATATTCC
CCACTGCTGCCTCCCGTAGGAGTCTGGGCCGTATCTCAGTCCCAATGTGGCCGGTCGCCCTCTC
AGGCCGGCTACCCGTCGAAACCTTGGTAGGCCACTACCCCACCAACAAGCTGATAGGACGCG
ATCCCATCGCATAGCACTAAAACGTTTTCCCACACACCCATGCGAGCATGTGGAACATTCGGC
ATTACCACCCGTTTCCAGGAGCTATTCCAAACTAC 
Accession Description Query coverage Max ident  
NR_042583.1 Alloscardovia omnicolens strain : CCUG 
31649 16S ribosomal RNA, complete 
sequence 
100% 99% 
NR_041347.1 Metascardovia criceti strain OMB105 16S 
ribosomal RNA, partial sequence 
100% 95% 
NR_044692.1 Bifidobacterium minimum 16S ribosomal 
RNA, complete sequence 
98% 93% 
 
Bifidobacterium breve UM031 (753 bp of sequence): 
AGATCACAGAGACCTGCCTTCGCCATTGGTGTTCTTCCCGATATCTACACATTCCACCGTTACA
CCGGGAATTCCAGTCTCCCCTACCGCACTCAAGCCCGCCCGTACCCGGCGCGGATCCACCGTT
AAGCGATGGACTTTCACACCGGACGCGACGAACCGCCTACGAGCCCTTTACGCCCAATAATTC
CGGATAACGCTTGCACCCTACGTATTACCGCGGCTGCTGGCACGTAGTTAGCCGGTGCTTATTC
GAAAGGTACACTCAACACAAAGTGCCTTGCTCCCTAACAAAAGAGGTTTACAACCCGAAGGC
CTCCATCCCTCACGCGGCGTCGCTGCATCAGGCTTGCGCCCATTGTGCAATATTCCCCACTGCT
GCCTCCCGTAGGAGTCTGGGCCGTATCTCAGTCCCAATGTGGCCGGTCGCCCTCTCAGGCCGG
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CTACCCGTCGAAGCCATGGTGGGCCGTTACCCCGCCATCAAGCTGATAGGACGCGACCCCATC
CCATGCCGCAAAGGCTTTCCCAACACACCATGCGGTGTGATGGAGCATCCGGCATTACCACCC
GTTTCCAGGAGCTATTCCGGTGCATGGGGCAGGTCGGTCACGCATTACTCACCCGTTCGCCAC
TCTCACCAGGCAGCAAGCTGCCTGGATCCCGTTCGACTTGCATGTGTTAAGCACGCCGCCAGC
GTTCATCCTGAGCCAGGATTC 
 
Streptococcus spp. UM031 (754 bp of sequence): 
GAGCCTCAGCGTCAGTTACAGACCAGAGAGCCGCTTTCGCCACCGGTGTTCCTCCATATATCT
ACGCATTTCACCGCTACACATGGAATTCCACTCTCCCCTTCTGCACTCAAGTTTGACAGTTTCC
AAAGCGAACTATGGTTGAGCCACAGCCTTTAACTTCAGACTTATCAAACCGCCTGCGCTCGCT
TTACGCCCAATAAATCCGGACAACGCTCGGGACCTACGTATTACCGCGGCTGCTGGCACGTAG
TTAGCCGTCCCTTTCTGGTAAGCTACCGTCACAGTGTGAACTTTCCACTCTCACACTCGTTCTT
GACTTACAACAGAGCTTTACGATCCGAAAACCTTCTTCACTCACGCGGCGTTGCTCGGTCAGG
GTTGCCCCCATTGCCGAAGATTCCCTACTGCTGCCTCCCGTAGGAGTCTGGGCCGTGTCTCAGT
CCCAGTGTGGCCGATCACCCTCTCAGGTCGGCTATGTATCGTCGCCTAGGTGAGCCGTTACCTC
ACCTACTAGCTAATACAACGCAGGTCCATCTTGTAGTGGAGCAATTGCCCCTTTCAAATAAAT
GACATGTGTCATCCATTGTTATGCGGTATTAGCTATCGTTTCCAATAGTTATCCCCCGCTACAA
GGCAGGTTACCTACGCGTTACTCACCCGTTCGCAACTCATCCAAGAAGAGCAAGCTCCTCTCT
TCAGCGTTCTACTTGCATGTATTAGGCACGCCGCCAGCGATCG 
 
 
Accession Description Query coverage Max ident  
NR_040783.1 Bifidobacterium breve DSM 20213 strain 
ATCC 15700 16S ribosomal RNA, partial 
sequence 
98% 99% 
NR_043442.1 Bifidobacterium pseudolongum subsp. 
pseudolongum strain JCM 1205 16S 
ribosomal RNA, partial sequence 
98% 95% 
NR_036854.1 Bifidobacterium boum strain RU917 16S 
ribosomal RNA, partial sequence 
98% 95% 
Accession Description Query coverage Max ident 
NR_042776.1 Streptococcus salivarius strain ATCC 7073 16S 
ribosomal RNA, complete sequence 
100% 99% 
NR_042778.1 Streptococcus thermophilus strain ATCC 19258 16S 
ribosomal RNA, complete sequence 
100% 99% 
NR_042777.1 Streptococcus vestibularis ATCC 49124 strain 
ATCC 49124 16S ribosomal RNA, complete 
sequence 
100% 99% 
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Bacillus firmus UM034 (744 bp of sequence): 
GTCGCCTTTCGCCACTGGTGTTCCTCCACATCTCTACGCATTTCACCGCTACACGTGGAATTCC
ACTCTTCTCTTCTGCACTCAAGTTCCCCAGTTTCCAATGACCCTCCCCGGTTGAGCCGGGGGCT
TTCACATCAGACTTAAGGAACCGCCTGCGCGCGCTTTACGCCCAATAATTCCGGACAACGCTT
GCCACCTACGTATTACCGCGGCTGCTGGCACGTAGTTAGCCGTGGCTTTCTGGTTAGGTACCGT
CAAGGTACCGGCAGTTACTCCGGTACTTGTTCTTCCCTAACAACAGAGTTTTACGATCCGAAA
ACCTTCATCACTCACGCGGCGTTGCTCCGTCAGACTTTCGTCCATTGCGGAAGATTCCCTACTG
CTGCCTCCCGTAGGAGTCTGGGCCGTGTCTCAGTCCCAGTGTGGCCGATCACCCTCTCAGGTCG
GCTACGCATCGTTGCCTTGGTGAGCCGTTACCTCACCAACTAGCTAATGCGCCGCGGGCCCAT
CTGTAAGTGATAGCCGAAACCATCTTTCAGCTTTCCCTCATGTGAGGGAAAGAATTATCCGGT
ATTAGCCCCGGTTTCCCGGAGTTATCCCAGTCTTACAGGCAGGTTGCCCACGTGTTACTCACCC
GTCCGCCGCTGACTTCAGGGAGCAAGCTCCCATCTGTCCGCTCGACTTGCATGTATTAGGCAC 
Accession Description Query coverage Max ident 
NR_025842.1 Bacillus firmus strain IAM 12464 16S ribosomal RNA, 
partial sequence 
100% 98% 
NR_043762.1 Bacillus thioparans strain BMP-1 16S ribosomal RNA, 
partial sequence 
99% 96% 
NR_044828.1 Bacillus benzoevorans strain NCIMB 12555 16S 
ribosomal RNA, partial sequence 
100% 96% 
 
Gardnerella vaginalis UM035 (456 of sequence): 
GCAGTCCAGAGACCTGCCTTCGCCATTGGTGTTCTTCCCGATATCTACACATTCCACCGTTACA
CCGGGAATTCCAGTCTCCCCTACTGCACTCTAGCCCGCCCGTACCCGGCGCAAACCCACCGTT
AAGCGATGGGCTTTCACACCAGACGCGACGAACCGCCTACAAGCTCTTTACGCCCAATAATTC
CGGATAACGCTTGCGCCCTACGTATTACCGCGGCTGCTGGCACGTAGTTAGCCGGCGCTTATT
CGAAAGGTACACTCACCCGAAAGCTTGCTCCCAATCAAAAGCGGTTTACAACCCGAAGGCCTT
CATCCCGCACGCGGCGTCGCTGCGTCAGGGTTTCCCCCATTGCGCAATATTCCCCACTGCTGCC
TCCCGTAAGAGTCTGGGCCGTATCTCAGTCCCAATGGGGCCGTCCG 
Accession Description Query coverage Max 
ident  
NR_044694.1 Gardnerella vaginalis 16S ribosomal RNA, complete 
sequence 
99% 98% 
NR_037117.1 Bifidobacterium pseudocatenulatum strain B1279 
16S ribosomal RNA, partial sequence 
97% 95% 
NR_041875.1 Bifidobacterium catenulatum strain ATCC27539 
16S ribosomal RNA, partial sequence 
97% 95% 
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Gemella spp. UM034 (745 of sequence): 
CGCGCTCAGTGTCAGTTACAGGCCAAAAAGCCGCCTTCGCCACTGGTGTTCCTCCTAATCTCTA
CGCATTTCACCGCTACACTAGGAATTCCACTTTTCTCTCCTGCACTCAAGTTTAACAGTTTCCA
ATGACCCTCCACGGTTGAGCCGTGGGCTTTCACATCAGACTTATTAAACCACCTGCGCGCGCTT
TACGCCCAATAATTCCGGACAACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACGTAGT
TAGCCGTGGCTTTCTGGTTAGGTACCGTCTCTACTGTGTATAGTTACTACACAATCATTCTTCC
CTAACAACAGAGCTTTACGAACCGAAATCCTTCTTCACTCACGCGGCGTTGCTCCGTCAGGCTT
TCGCCCATTGCGGAAGATTCCCTACTGCTGCCTCCCGTAGGAGTCTGGGCCGTGTCTCAGTCCC
AGTGTGGCCGATCACCCTCTCAGGTCGGCTATGCATCGTCGCCTTGGTAGGCCTTTACCCCACC
AACTAGCTAATGCACCGCAAAGCCATCTCATAGTGTTAGCAAAACCAACTTTCAAACATCAAC
CATGCAGTTAATGCTGTTATCCGGTATTAGCTATCGTTTCCAATAGTTGTCCCAGTCTATGAGG
CAGGTTCTTTACGTGTTACTCACCCGTTCGCCGCTAAGTTTTTCTAGTGCAAGCACCAGAAAAA
CTTCGCTCGACTTGCATGTATTAGGCAAGC 
Accession Description Query coverage Max ident  
NR_025903.1 Gemella haemolysans strain ATCC 10379 16S 
ribosomal RNA, partial sequence 
99% 99% 
NR_026419.1 Gemella sanguinis strain 2045-94 16S ribosomal 
RNA, partial sequence 
99% 98% 
NR_025904.1 Gemella morbillorum strain 2917B 16S ribosomal 
RNA, partial sequence 
99% 98% 
 
Klebsiella spp. UM034 (734 of sequence): 
CGCACTGAGCGTCAGTCTTTGTCCAGGGGGCCGCCTTCGCCACCGGTATTCCTCCAGATCTCTA
CGCATTTCACCGCTACACCTGGAATTCTACCCCCCTCTACAAGACTCTAGCCTGCCAGTTTCGA
ATGCAGTTCCCAGGTTGAGCCCGGGGATTTCACATCCGACTTGACAGACCGCCTGCGTGCGCT
TTACGCCCAGTAATTCCGATTAACGCTTGCACCCTCCGTATTACCGCGGCTGCTGGCACGGAGT
TAGCCGGTGCTTCTTCTGCGGGTAACGTCAATCGCCAAGGTTATTAACCTTAACGCCTTCCTCC
CCGCTGAAAGTGCTTTACAACCCGAAGGCCTTCTTCACACACGCGGCATGGCTGCATCAGGCT
TGCGCCCATTGTGCAATATTCCCCACTGCTGCCTCCCGTAGGAGTCTGGACCGTGTCTCAGTTC
CAGTGTGGCTGGTCATCCTCTCAGACCAGCTAGGGATCGTCGCCTAGGTGAGCCGTTACCCCA
CCTACTAGCTAATCCCATCTGGGCACATCTGATGGCATGAGGCCCGAAGGTCCCCCACTTTGG
TCTTGCGACGTTATGCGGTATTAGCTACCGTTTCCAGTAGTTATCCCCCTCCATCAGGCAGTTT
CCCAGACATTACTCACCCGTCCGCCGCTCGTCACCCGAGAGCAAGCTCTCTGTGCTACCGCTC
GACTTGCATGTGTTAGGCCTGC 
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Accession Description Query coverage Max ident  
NR_041750.1 Klebsiella pneumoniae subsp. ozaenae strain 
ATCC11296 16S ribosomal RNA, partial 
sequence 
100% 99% 
NR_037084.1 Klebsiella pneumoniae subsp. 
rhinoscleromatis strain R-70 16S ribosomal 
RNA, partial sequence 
100% 99% 
NR_024643.1 Enterobacter aerogenes strain JCM1235 16S 
ribosomal RNA, partial sequence 
100% 99% 
 
 
Propionibacterium acnes UM034 (745 of sequence): 
AAATCAGCGTCAGGAAGGCCCAGAGAACCGCCTTCGCCACTGGTGTTCCTCCTGATATCTGCG
CATTCCACCGCTCCACCAGGAATTCCATTCTCCCCTACCTTCCTCAAGTCAACCCGTATCGAAA
GCACGCTCAGGGTTAAGCCCCAAGATTACACTTCCGACGCGATCAACCACCTACGAGCCCTTT
ACGCCCAATAAATCCGGACAACGCTCGCACCCTACGTATCACCGCGGCTGCTGGCACGTAGTT
AGCCGGTGCTTCTTTACCCATTACCGTCACTCACGCTTCGTCACAGGCGAAAGCGGTTTACAAC
CCGAAGGCCGTCATCCCGCACGCGGCGTTGCTGCATCAGGCTTCCGCCCATTGTGCAATATTC
CCCACTGCTGCCTCCCGTAGGAGTCTGGGCCGTATCTCAGTCCCAATGTGGCCGGTCACCCTCT
CAGGCCGGCTACCCGTCAAAGCCTTGGTAAGCCACTACCCCACCAACAAGCTGATAAGCCGCG
AGTCCATCCCCAACCGCCGAAACTTTCCAACCCCCACCATGCAGCAGGAGCTCCTATCCGGTA
TTAGCCCCAGTTTCCTGAAGTTATCCCAAAGTCAAGGGCAGGTTACTCACGTGTTACTCACCCG
TTCGCCACTCGAGCACCCCACAAAAGCAGGGCCTTTCCGTTCGACTTGCATGTGTTAAGCACG
CCGCCAGCGTTCGTCCTGAGCCAGTCTA 
Accession Description Query coverage Max ident  
NR_040847.1 Propionibacterium acnes 16S ribosomal RNA, 
complete sequence 
99% 99% 
NR_025277.1 Propionibacterium propionicum strain DSM 43307 
16S ribosomal RNA, partial sequence 
98% 95% 
NR_025274.1 Propionibacterium avidum strain DSM 4901 16S 
ribosomal RNA, partial sequence 
98% 95% 
 
Enterococcus faecalis UM035 (759 of sequence): 
GAGCTCAGCGTCAGTTACAGACCAGAGAGCCGCCTTCGCCACTGGTGTTCCTCCATATATCTA
CGCATTTCACCGCTACACATGGAATTCCACTCTCCTCTTCTGCACTCAAGTCTCCCAGTTTCCA
ATGACCCTCCCCGGTTGAGCCGGGGGCTTTCACATCAGACTTAAGAAACCGCCTGCGCTCGCT
TTACGCCCAATAAATCCGGACAACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACGTAG
TTAGCCGTGGCTTTCTGGTTAGATACCGTCAGGGGACGTTCAGTTACTAACGTCCTTGTTCTTC
TCTAACAACAGAGTTTTACGATCCGAAAACCTTCTTCACTCACGCGGCGTTGCTCGGTCAGACT
TTCGTCCATTGCCGAAGATTCCCTACTGCTGCCTCCCGTAGGAGTCTGGGCCGTGTCTCAGTCC
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CAGTGTGGCCGATCACCCTCTCAGGTCGGCTATGCATCGTGGCCTTGGTGAGCCGTTACCTCAC
CAACTAGCTAATGCACCGCGGGTCCATCCATCAGCGACACCCGAAAGCGCCTTTCACTCTTAT
GCCATGCGGCATAAACTGTTATGCGGTATTAGCACCTGTTTCCAAGTGTTATCCCCCTCTGATG
GGTAGGTTACCCACGTGTTACTCACCCGTCCGCCACTCCTCTTTCCAATTGAGTGCAAGCACTC
GGGAGGAAAGAAGCGTTCGACTTGCATGTATTAGGCACGCCGCCA 
Accession Description Query coverage Max ident  
NR_040789.1 Enterococcus faecalis strain JCM 5803 16S ribosomal 
RNA, partial sequence 
100% 99% 
NR_042405.1 Enterococcus silesiacus strain : LMG 23085 = R-
23712 16S ribosomal RNA, complete sequence 
100% 96% 
NR_043285.1 Enterococcus caccae strain 2215-02 16S ribosomal 
RNA, partial sequence 
100% 96% 
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